Nontraumatic intracranial haemmorrhage

I9_INTRACRA

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters None 0 out of 7 registries used, show all original rules.	0
4. Check minimum number of events None	0
5. Include endpoints I9_SAH I9_ICH	8890
6. Filter based on genotype QC (FinnGen only)	8890

Control definitions (FinnGen only)

Control exclude: I9_CEREBVASC

Extra metadata

Level in the ICD hierarchy: C
First used in FinnGen datafreeze: DF2

NAME	I9_INTRACRA
CONTROL_EXCLUDE	I9_CEREBVASC
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	I9_SAH\|I9_ICH
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Nontraumatic intracranial haemmorrhage based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	120107	57004	60805
Only index persons	69638	34146	35492
Unadjusted period prevalence (%)
Whole population	1.68	1.63	1.70
Only index persons	1.31	1.26	1.35
Median age at first event (years)
Whole population	66.34	69.20	63.72
Only index persons	66.62	69.27	64.07

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	8890	3968	4922
Unadjusted period prevalence (%)	1.81	1.35	2.17
Median age at first event (years)	63.96	61.50	65.94

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
8031: Matched controls
80273

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

3.3

323.3

1985

7302

I63.4

ICD-10 Finland

Cerebral infarction due to embolism of cerebral arteries

1678.3

323.0

313

I60.7

ICD-10 Finland

Subarachnoid haemorrhage from intracranial artery, unspecified

+∞

323.0

416

I69.0

ICD-10 Finland

Sequelae of subarachnoid haemorrhage

3016.9

323.0

1095

K90

ICPC

Stroke/cerebrovascular accident

46.8

323.0

749

176

I63.3

ICD-10 Finland

Cerebral infarction due to thrombosis of cerebral arteries

1282.3

323.0

483

I60.1

ICD-10 Finland

Subarachnoid haemorrhage from middle cerebral artery

7232.2

323.0

675

PA2CC

NOMESCO Finland

Cerebral very extensive angiography with X-ray

299.3

323.0

477

AAF00

NOMESCO Finland

Ventriculostomy

108.3

323.0

508

2161

FHL

Neck ligation, big brain

+∞

323.0

381

AA1AD

NOMESCO Finland

CT of head and brain

5.8

323.0

3755

10571

I60.2

ICD-10 Finland

Subarachnoid haemorrhage from anterior communicating artery

+∞

323.0

563

I60.9

ICD-10 Finland

Subarachnoid haemorrhage, unspecified

3816.9

323.0

1860

I61.9

ICD-10 Finland

Intracerebral haemorrhage, unspecified

2451.3

323.0

1953

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

8.1

323.0

1026

1422

AAC00

NOMESCO Finland

Ligature of intracranial aneurysm

+∞

323.0

857

PA2BD

NOMESCO Finland

Extensive CT angiography of brain

50.7

323.0

772

168

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

146.8

323.0

1417

117

I69.1

ICD-10 Finland

Sequelae of intracerebral haemorrhage

1506.5

323.0

1271

I61.0

ICD-10 Finland

Intracerebral haemorrhage in hemisphere, subcortical

5178.1

323.0

2026

I67.1

ICD-10 Finland

Cerebral aneurysm, nonruptured

1185.9

323.0

655

I61.1

ICD-10 Finland

Intracerebral haemorrhage in hemisphere, cortical

+∞

323.0

769

4300A

ICD-9 Finland

Subarachnoid haemorrhage[HAEMORRHAGIA SUBARACHNOID. POST ANEURYSMA SACCULARE]

+∞

323.0

434

I60.0

ICD-10 Finland

Subarachnoid haemorrhage from carotid siphon and bifurcation

+∞

323.0

429

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

100.2

323.0

1217

143

PA2BC

NOMESCO Finland

Cerebral extensive angiography with X-ray

224.4

323.0

564

XA800

NOMESCO Finland

Neuropsychological investigation

11.3

323.0

649

620

I61.4

ICD-10 Finland

Intracerebral haemorrhage in cerebellum

+∞

311.4

297

N03AX14

ATC

levetiracetam; systemic

12.6

309.2

575

487

S06.5

ICD-10 Finland

Traumatic subdural haemorrhage

7.8

304.9

749

1050

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

3.0

285.5

2021

8112

PA2LT

NOMESCO Finland

Endovascular closure of extensive brain aneurysm

+∞

273.4

261

N18

ICPC

Paralysis/weakness

16.0

258.2

432

284

K91

ICPC

Cerebrovascular disease

31.0

250.7

339

114

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

13.2

247.7

449

357

I60.8

ICD-10 Finland

Other subarachnoid haemorrhage

+∞

246.0

235

I61.8

ICD-10 Finland

Other intracerebral haemorrhage

1218.7

243.7

237

G40.9

ICD-10 Finland

Epilepsy, unspecified

7.8

243.0

590

805

43090

ICD-8 Finland

Subarachnoid haemorrhage, Postaneurysma sacculare, hypertonia non indicata

+∞

242.8

232

AA5BD

NOMESCO Finland

CT of cerebral ischaemia

20.9

239.5

363

181

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

11.8

221.9

425

379

AAL00

NOMESCO Finland

Endovascular occlusion of intracranial aneurysm

+∞

217.6

208

N03AB02

ATC

phenytoin; systemic

14.4

214.5

374

271

I60.3

ICD-10 Finland

Subarachnoid haemorrhage from posterior communicating artery

+∞

211.3

202

PA3AC

NOMESCO Finland

Carotis angiography with X-ray

314.9

210.5

213

I60.6

ICD-10 Finland

Subarachnoid haemorrhage from other intracranial arteries

+∞

200.8

192

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

11.0

200.5

396

375

AAF05

NOMESCO Finland

Ventriculoperitoneal shunt

13.2

199.0

361

286

I61.5

ICD-10 Finland

Intracerebral haemorrhage, intraventricular

1801.5

192.2

186

N03AF02

ATC

oxcarbazepine; oral

7.4

189.5

476

679

S06.3

ICD-10 Finland

Focal brain injury

12.7

189.1

349

287

I61.3

ICD-10 Finland

Intracerebral haemorrhage in brain stem

+∞

187.1

179

PA2KT

NOMESCO Finland

Endovascular closure of brain aneurysm

+∞

186.1

178

I61.6

ICD-10 Finland

Intracerebral haemorrhage, multiple localized

908.0

182.0

178

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

4.1

181.8

782

2077

I63.0

ICD-10 Finland

Cerebral infarction due to thrombosis of precerebral arteries

1842.5

177.6

172

R4120

NOMESCO Finland

Occupational therapy

4.6

177.3

661

1528

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

4.7

177.2

645

1455

43099

ICD-8 Finland

Subarachnoid haemorrhage, Without mention of hypertension

+∞

173.5

166

G91.0

ICD-10 Finland

Communicating hydrocephalus

28.8

173.0

238

4309X

ICD-9 Finland

Subarachnoid haemorrhage[HAEMORRHAGIA SUBARACHNOIDALIS NUD]

+∞

171.4

164

S06.6

ICD-10 Finland

Traumatic subarachnoid haemorrhage

13.8

164.2

291

218

R51.80

ICD-10 Finland

Headache

2.8

160.7

1151

4470

AAB30

NOMESCO Finland

Evacuation of spontaneous intracranial haematoma

1627.8

159.8

155

I60.4

ICD-10 Finland

Subarachnoid haemorrhage from basilar artery

+∞

156.7

150

4380A

ICD-9 Finland

Late effects of cerebrovascular disease[SEQUELAE MORBI CEREBROVASCULARIS]

+∞

153.6

147

PA2AC

NOMESCO Finland

Cerebral angiography with X-ray

225.5

150.5

155

H53.4

ICD-10 Finland

Visual field defects

9.6

147.5

312

335

R4150

NOMESCO Finland

Neuropsychological rehabilitation

46.2

146.6

181

R56.8

ICD-10 Finland

Other and unspecified convulsions

4.4

143.3

563

1364

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

5.5

141.3

441

834

PA2AD

NOMESCO Finland

CT angiography of brain

38.9

140.0

179

PA2MT

NOMESCO Finland

Endovascular closure of very extensive brain aneurysm

+∞

138.9

133

I63.1

ICD-10 Finland

Cerebral infarction due to embolism of precerebral arteries

+∞

137.8

132

AA5PD

NOMESCO Finland

CT examination of brain pefusion

44.8

134.5

167

I62.0

ICD-10 Finland

Nontraumatic subdural haemorrhage

327.0

128.8

130

N03AG01

ATC

valproic acid; systemic, rectal

3.7

126.4

590

1666

I61

ICD-10 Finland

Intracerebral haemorrhage

190.0

125.9

131

PA2YT

NOMESCO Finland

Cerebral artery PTA with stent

1226.3

124.3

121

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.2

121.9

1475

7475

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.8

120.7

2653

16960

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

3.0

119.9

771

2762

I61.2

ICD-10 Finland

Intracerebral haemorrhage in hemisphere, unspecified

+∞

116.9

112

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

3.2

116.8

668

2206

I63.8

ICD-10 Finland

Other cerebral infarction

137.5

114.4

122

R47.0

ICD-10 Finland

Dysphasia and aphasia

19.4

113.3

175

I10

ICD-10 Finland

Essential (primary) hypertension

1.7

111.7

4959

39003

N03AF01

ATC

carbamazepine; oral, rectal

3.3

110.6

604

1925

4340A

ICD-9 Finland

Occlusion of cerebral arteries, Cerebral thrombosis

+∞

109.6

105

205

Kela drug reimbursment

Chronic hypertension

1.8

107.9

2824

18928

4310A

ICD-9 Finland

Intracerebral haemorrhage[HAEMORRHAGIA INTRACEREBRALIS CUM HYPERTONIA]

+∞

107.5

103

PA4AC

NOMESCO Finland

Vertebralis angiography with X-ray

117.6

107.2

116

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

6.9

104.7

273

408

I65.2

ICD-10 Finland

Occlusion and stenosis of carotid artery

50.3

102.3

124

I69.2

ICD-10 Finland

Sequelae of other nontraumatic intracranial haemorrhage

508.9

101.8

101

I63.5

ICD-10 Finland

Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteries

334.3

99.2

100

G40.20

ICD-10 Finland

Complex partial seizures with only alteration of consciousness

11.7

99.0

188

164

R4130

NOMESCO Finland

Speech therapy

6.8

97.5

255

383

I69.8

ICD-10 Finland

Sequelae of other and unspecified cerebrovascular diseases

72.0

93.5

107

T90.5

ICD-10 Finland

Sequelae of intracranial injury

10.3

91.2

185

184

N19

ICPC

Speech disorder

11.4

90.9

175

157

AAD15

NOMESCO Finland

Evacuation of traumatic intracerebral haematoma

85.2

90.2

101

4311A

ICD-9 Finland

Intracerebral haemorrhage[HAEMORRHAGIA INTRACEREBRALIS HYPERTONIA NON INDICAT]

+∞

88.7

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

5.0

86.2

293

608

4373A

ICD-9 Finland

Other and ill-defined cerebrovascular disease, Cerebral aneurysm, nonruptured

+∞

83.4

I64

ICD-10 Finland

Stroke, not specified as haemorrhage or infarction

55.6

83.2

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

4.3

82.5

323

774

4319X

ICD-9 Finland

Intracerebral haemorrhage[HAEMORRHAGIA INTRACEREBRALIS NUD]

+∞

82.4

WX892

NOMESCO Finland

Monitored bed care

2.5

81.3

678

2815

AAD10

NOMESCO Finland

Evacuation of chronic subdural haematoma

6.7

80.1

212

324

C08CA01

ATC

amlodipine; oral

1.6

78.7

3006

21857

I67.9

ICD-10 Finland

Cerebrovascular disease, unspecified

42.1

76.8

Q28.2

ICD-10 Finland

Arteriovenous malformation of cerebral vessels

39.3

76.4

R1260

NOMESCO Finland

Evaluation of communicative skills

6.2

76.4

214

353

AA9CW

NOMESCO Finland

59.9

75.8

PAF14

NOMESCO Finland

Thrombendarterectomy of internal carotid artery

42.7

74.6

WX730

NOMESCO Finland

Conventional respirator

5.5

73.7

226

417

PA7BD

NOMESCO Finland

CT angiography of neck and brain

7.0

73.3

188

275

I60.5

ICD-10 Finland

Subarachnoid haemorrhage from vertebral artery

+∞

71.9

PA7CD

NOMESCO Finland

CT angiography of neck and brain, extensive

9.6

71.8

150

158

PA2BG

NOMESCO Finland

MRI examination of vessels in the head with high intensity magnet

19.7

71.3

109

XF400

NOMESCO Finland

ECG with 12 standard connections

1.8

71.0

1409

8441

I63.2

ICD-10 Finland

Cerebral infarction due to unspecified occlusion or stenosis of precerebral arteries

241.9

70.4

C08CA06

ATC

nimodipine; systemic

79.8

70.1

XXA00

NOMESCO Finland

Clinical examination requiring general anaesthesia

13.2

69.5

124

G40.10

ICD-10 Finland

Simple partial seizures

11.9

69.3

130

111

I62.9

ICD-10 Finland

Intracranial haemorrhage (nontraumatic), unspecified

683.6

69.1

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.6

68.6

2170

14894

W19

ICD-10 Finland

Unspecified fall

2.2

68.3

803

3939

G40.2

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

10.2

67.7

137

136

B01AC04

ATC

clopidogrel; oral

1.8

67.5

1286

7585

A28

ICPC

Limited function/disability NOS

1.8

66.8

1433

8784

G40.12

ICD-10 Finland

Simple partial seizures with secondary generalization

11.5

64.7

123

108

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

4.2

63.8

251

605

D68.3

ICD-10 Finland

Haemorrhagic disorder due to circulating anticoagulants

13.5

63.4

112

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

3.0

61.4

371

1261

G40.19

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures

13.1

58.3

104

R1230

NOMESCO Finland

Neuropsychological evaluation of need and possibilities to rehabilitation

10.3

56.3

113

111

TKC20

NOMESCO Finland

Catheterisation of bladder

2.1

56.2

667

3270

I60

ICD-10 Finland

Subarachnoid haemorrhage

194.5

56.0

G81.9

ICD-10 Finland

Hemiplegia, unspecified

10.9

56.0

109

101

B01AC07

ATC

dipyridamole; systemic

2.5

55.9

475

1983

AAD05

NOMESCO Finland

Evacuation of acute subdural haematoma

13.3

55.9

B01AA03

ATC

warfarin; systemic

1.6

55.0

1899

13184

GBB00

NOMESCO Finland

Tracheostomy

5.3

54.8

172

327

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.2

53.7

588

2781

G45.1

ICD-10 Finland

Carotid artery syndrome (hemispheric)

3.3

53.5

289

908

N28

ICPC

Limited function/disability (N)

4.8

53.4

183

384

SPAT1224

SPAT

Implementation of speech therapy rehabilitation plan

6.0

51.7

147

248

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.2

51.7

576

2744

N03AX18

ATC

lacosamide; systemic

10.6

51.3

101

AAF20

NOMESCO Finland

Revision of shunt of ventricle of brain

12.0

50.7

G41.9

ICD-10 Finland

Status epilepticus, unspecified

10.4

49.7

Q28.3

ICD-10 Finland

Other malformations of cerebral vessels

20.7

49.5

G91.1

ICD-10 Finland

Obstructive hydrocephalus

13.4

47.7

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.8

47.4

326

1205

XCK00

NOMESCO Finland

Perimetry

2.1

47.1

559

2735

43000

ICD-8 Finland

Subarachnoid haemorrhage, Post aneyrisma sacculare, cum hypertonia

+∞

46.9

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

2.3

46.7

462

2082

S06.0

ICD-10 Finland

Concussion

1.9

45.5

723

3968

SPAT1229

SPAT

Assessment of need for aid

1.9

45.3

704

3831

C09AA05

ATC

ramipril; oral

1.5

44.9

2018

14766

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.9

44.9

703

3839

I69

ICD-10 Finland

Sequelae of cerebrovascular disease

26.0

44.5

183

Kela drug reimbursment

Lamotrigin and topiramate

8.1

44.3

102

128

AAC40

NOMESCO Finland

Extirpation of intracranial arterio-venous malformation

439.8

44.2

G91.9

ICD-10 Finland

Hydrocephalus, unspecified

10.4

43.9

WX872

NOMESCO Finland

Intensive care

2.3

43.6

413

1822

M01AH05

ATC

etoricoxib; oral

0.7

43.6

2456

30812

R42

ICD-10 Finland

Dizziness and giddiness

1.5

42.7

1579

11043

G40

ICD-10 Finland

Epilepsy

7.7

42.6

101

133

L28

ICPC

Limited function/disability (L)

1.6

41.9

1268

8444

I67.3

ICD-10 Finland

Progressive vascular leukoencephalopathy

9.5

41.9

SPAT1216

SPAT

Assessment of functional ability

1.6

41.5

1263

8424

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.8

40.9

709

4005

AAL10

NOMESCO Finland

Intracranial endovascular thrombolysis

210.9

40.9

PA2VT

NOMESCO Finland

Intravascular evacuation of brain artery embolus

+∞

40.6

I69.4

ICD-10 Finland

Sequelae of stroke, not specified as haemorrhage or infarction

399.2

40.1

AAK80

NOMESCO Finland

Partial excision of skull cap

399.2

40.1

FFM32

NOMESCO Finland

Occlusion or excision of atrial appendage transvenously with a closing device

44.7

40.0

S01.0

ICD-10 Finland

Open wound of scalp

1.9

39.9

603

3246

FFW96

NOMESCO Finland

Other operation on atria

26.3

39.7

C09AA02

ATC

enalapril; systemic

1.5

39.5

1683

12114

M03BX01

ATC

baclofen; systemic

4.5

39.3

145

330

R55

ICD-10 Finland

Syncope and collapse

1.7

38.7

858

5238

R41.0

ICD-10 Finland

Disorientation, unspecified

2.6

38.7

298

1176

N88

ICPC

Epilepsy

10.0

38.5

C02AC05

ATC

moxonidine; oral

2.3

38.1

383

1736

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

4.2

38.0

150

365

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

1.9

37.6

565

3032

N06AB04

ATC

citalopram; systemic

1.5

37.4

1394

9730

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

2.0

37.3

523

2734

C07AB07

ATC

bisoprolol; oral

1.4

37.3

3728

31280

R47.1

ICD-10 Finland

Dysarthria and anarthria

6.7

37.2

147

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.2

36.7

398

1869

G46.3*I67.9

ICD-10 Finland

Brain stem stroke syndrome (I60-I67+)

+∞

36.5

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.8

36.4

671

3865

N05AH04

ATC

quetiapine; oral

1.6

36.4

940

5985

I67.6

ICD-10 Finland

Nonpyogenic thrombosis of intracranial venous system

358.7

36.0

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.6

35.7

1185

8042

S06.2

ICD-10 Finland

Diffuse brain injury

5.0

35.4

116

234

N05BA09

ATC

clobazam; oral

10.1

35.3

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.5

35.3

1281

8875

R53

ICD-10 Finland

Malaise and fatigue

1.5

35.0

1417

10057

R4110

NOMESCO Finland

Physiotherapy

1.4

34.9

1768

13134

AAK00

NOMESCO Finland

Cranioplasty

43.1

34.9

AAA27

NOMESCO Finland

Insertion of intracerebral pressure monitoring device

46.8

34.6

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

3.5

34.6

170

499

I63

ICD-10 Finland

Cerebral infarction

20.5

34.3

SPAT1231

SPAT

Assessment of adjustments needed in living environment

3.0

34.2

202

676

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.0

34.0

445

2261

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.4

33.6

299

1279

WX882

NOMESCO Finland

High dependency care

2.7

33.4

230

853

43098

ICD-8 Finland

Subarachnoid haemorrhage, Alia definita, hypertonia non indicata

+∞

33.3

AAF25

NOMESCO Finland

Removal of shunt of ventricle of brain

17.4

33.1

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.2

33.0

365

1730

AA7AA

NOMESCO Finland

Liquor cerebri shunt X-ray examinatin without contrast

11.8

33.0

AA1BM

NOMESCO Finland

MRI examination of brain with 3 Tesla magnet

5.5

32.5

180

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.1

32.4

407

2036

43190

ICD-8 Finland

Cerebral haemorrhage, Intracerebralis, hypertonia non indicata

+∞

32.3

X59

ICD-10 Finland

Exposure to unspecified factor

1.5

32.1

1143

7868

C07AB02

ATC

metoprolol; systemic

1.4

31.9

1768

13322

TAB00

NOMESCO Finland

Lumbar puncture

2.5

31.9

266

1099

G46.4*I67.9

ICD-10 Finland

Cerebellar stroke syndrome

113.7

31.7

A06AD11

ATC

lactulose; oral

1.5

31.6

1243

8746

I67.8

ICD-10 Finland

Other specified cerebrovascular diseases

47.6

31.5

P20

ICPC

Memory disturbance

1.5

31.2

1031

6969

A98

ICPC

Health maint/preventive medicine

0.7

31.0

5775

62412

C10AA01

ATC

simvastatin; oral

1.3

30.9

3436

28979

YKA02

NOMESCO Finland

Excision of kidneys from cadaver donor

160.5

30.7

AA1BD

NOMESCO Finland

Extensive CT of head and brain

2.7

30.7

214

801

AAF15

NOMESCO Finland

Ventriculoatrial shunt

11.2

30.2

N06AB10

ATC

escitalopram; oral

1.5

30.0

1010

6856

XFP96

NOMESCO Finland

Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation

2.7

29.9

212

800

SPAT1234

SPAT

Support of social functional capacity

1.9

29.2

430

2286

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.9

28.8

413

2176

N05AX08

ATC

risperidone; systemic

1.7

28.7

599

3579

AA1DM

NOMESCO Finland

Very extensive MRI examination of brain with 3 Tesla magnet

6.3

28.5

124

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.4

28.2

1978

15485

I67.0

ICD-10 Finland

Dissection of cerebral arteries, nonruptured

+∞

28.1

4301A

ICD-9 Finland

Subarachnoid haemorrhage[HAEMORRHAGIA SUBARACH.POST MALFORMAT.ARTERIOVENOSAM]

+∞

28.1

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.5

28.1

1029

7113

G81.1

ICD-10 Finland

Spastic hemiplegia

39.0

28.0

N80

ICPC

Head injury other

3.5

27.9

135

393

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.5

27.7

966

6604

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

1.9

27.5

404

2146

S02.11

ICD-10 Finland

Fracture of base of skull, open

8.5

27.3

SPAT1254

SPAT

Administration of medicine

1.5

27.1

1069

7503

PA2CG

NOMESCO Finland

Extensive MRI examination of vessels in the head with high intensity magnet

15.8

27.1

43009

ICD-8 Finland

Subarachnoid haemorrhage, NUD, cum hypertonia

+∞

27.1

43199

ICD-8 Finland

Cerebral haemorrhage, Without mention of hypertension

+∞

27.1

PA7RT

NOMESCO Finland

Medical infusion to cerebral artery

271.7

26.7

TPX22

NOMESCO Finland

Intravenous arterial thrombolysis

11.7

26.6

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.2

26.3

288

1360

G44.2

ICD-10 Finland

Tension-type headache

1.6

26.1

670

4245

4318X

ICD-9 Finland

Intracerebral haemorrhage[HAEMORRHAGIA INTRACEREBRALIS ALIA DEFINITA]

+∞

26.0

G93.90

ICD-10 Finland

Brain death

261.2

25.7

XX4AW

NOMESCO Finland

24.1

25.6

I68.0*E85.9

ICD-10 Finland

Cerebral amyloid angiopathy

135.3

25.6

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.5

25.5

985

6877

PAN14

NOMESCO Finland

Plastic repair of arteries internal carotid artery

44.4

25.5

D21

ICPC

Swallowing problem

3.6

25.2

117

331

S02.00

ICD-10 Finland

Fracture of the upper part of the head closed

7.6

25.2

2132

FHL

Ventricular operators sunt

58.1

25.0

C03CA01

ATC

furosemide; systemic

1.3

24.8

2554

21095

N06AX11

ATC

mirtazapine; oral

1.3

24.8

1951

15489

I67.2

ICD-10 Finland

Cerebral atherosclerosis

19.5

24.7

PA6AD

NOMESCO Finland

CT of neck arteries

4.8

24.5

171

S06.8

ICD-10 Finland

Other intracranial injuries

12.3

24.4

SPAT1245

SPAT

Provision of support and information to patient’s family members

1.9

24.0

380

2077

G94.2

ICD-10 Finland

Hydrocephalus in other diseases classified elsewhere

67.6

23.8

AA1AA

NOMESCO Finland

Head X-ray examination

4.2

23.7

223

N03AX09

ATC

lamotrigine; oral

2.4

23.6

207

881

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.7

23.5

569

3543

Z02.4

ICD-10 Finland

Examination for driving licence

0.7

23.5

1046

13923

G40.89

ICD-10 Finland

Other epilepsy

8.8

23.4

43091

ICD-8 Finland

Subarachnoid haemorrhage, Postaneyrisma arteriovenosum, hypertonia non indicata

+∞

22.9

XA400

NOMESCO Finland

EEG

6.2

22.9

101

I68.0

ICD-10 Finland

Cerebral amyloid angiopathy

65.1

22.8

C08CA02

ATC

felodipine; oral

1.5

22.8

762

5146

3313A

ICD-9 Finland

Other cerebral degenerations, Communicating hydrocephalus

18.9

22.5

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.7

22.4

474

2839

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.5

22.3

701

4667

G40.1

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures

9.2

22.2

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.7

22.2

449

2656

F05.9

ICD-10 Finland

Delirium, unspecified

2.6

22.1

165

645

C09BA02

ATC

enalapril and diuretics; systemic

1.6

22.1

654

4292

G91.8

ICD-10 Finland

Other hydrocephalus

19.5

22.1

N05BA01

ATC

diazepam; systemic, rectal

1.5

21.9

876

6150

43399

ICD-8 Finland

Cerebral thrombosis, Without mention of hypertension

+∞

21.9

SPAT1252

SPAT

Overall medication plan or its review

1.6

21.8

534

3335

Z50.5

ICD-10 Finland

Speech therapy

3.8

21.7

247

W10

ICD-10 Finland

Fall on and from stairs and steps

1.9

21.6

318

1692

C10AA05

ATC

atorvastatin; oral

1.3

21.1

2617

22036

S06.4

ICD-10 Finland

Epidural haemorrhage

11.5

21.1

XX2BT

NOMESCO Finland

Other injection with X-ray guidance

14.6

21.1

AAB00

NOMESCO Finland

Extirpation of intracranial lesion

3.4

21.0

105

316

43100

ICD-8 Finland

Cerebral haemorrhage, Intracerebralis, cum hypertonia

+∞

20.8

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.2

20.7

206

933

RS221

NOMESCO Finland

3.3

20.6

105

321

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.4

20.5

954

6897

G40.21

ICD-10 Finland

Partial epileptic seizure with cloudiness and automatism

8.0

20.4

G91.2

ICD-10 Finland

Normal-pressure hydrocephalus

2.8

20.2

128

454

C08CA05

ATC

nifedipine; systemic

1.6

20.2

509

3204

WX704

NOMESCO Finland

Intubation

1.7

20.0

415

2476

XX3XW

NOMESCO Finland

5.5

20.0

108

GBB03

NOMESCO Finland

Percutaneous tracheostomy

20.8

19.9

F01.9

ICD-10 Finland

Vascular dementia, unspecified

2.8

19.8

130

471

A12BA01

ATC

potassium chloride; oral

1.7

19.6

437

2657

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.5

19.6

777

5439

R51

ICD-10 Finland

Headache

2.0

19.6

251

1268

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.5

19.6

664

4495

WW806

NOMESCO Finland

Transfer from treating institution to lower-Level care, accompanied by doctor

105.2

19.5

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

1.7

19.5

451

2774

TPH04

NOMESCO Finland

Cathetrisation of vein

1.4

19.5

1331

10286

TPH07

NOMESCO Finland

Cathetrisation of artery

1.5

19.2

685

4691

315

Kela drug reimbursment

Clopidogrel

3.8

19.0

210

G942, I602

ICD-10 Finland

+∞

18.7

AA1AM

NOMESCO Finland

Short MRI examination of brain with 3 Tesla magnet

11.8

18.7

N02BE01

ATC

paracetamol; systemic, rectal

1.3

18.7

6045

56605

I65.0

ICD-10 Finland

Occlusion and stenosis of vertebral artery

100.2

18.5

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

4.7

18.4

132

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

2.5

18.3

148

608

H49.2

ICD-10 Finland

Sixth [abducent] nerve palsy

3.8

18.2

209

H53.2

ICD-10 Finland

Diplopia

2.2

18.2

186

855

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.0

18.0

236

1206

S06.9

ICD-10 Finland

Intracranial injury, unspecified

4.5

17.8

141

N30.0

ICD-10 Finland

Acute cystitis

1.4

17.8

829

5989

JDB10

NOMESCO Finland

Percutaneous gastrostomy

3.0

17.7

104

353

4308X

ICD-9 Finland

Subarachnoid haemorrhage[HAEMORRHAGIA SUBARACHNOIDALIS ALIA DEFINITA]

+∞

17.7

SPAT1296

SPAT

Other function in accordance with occupational therapy nomenclature

3.1

17.7

320

T85.0

ICD-10 Finland

Mechanical complication of ventricular intracranial (communicating) shunt

8.8

17.6

C03AA03

ATC

hydrochlorothiazide; oral

1.5

17.5

717

5046

I62.1

ICD-10 Finland

Nontraumatic extradural haemorrhage

180.2

17.5

H49.0

ICD-10 Finland

Third [oculomotor] nerve palsy

5.3

17.4

101

A41.9

ICD-10 Finland

Sepsis, unspecified

1.9

17.2

268

1459

3454A

ICD-9 Finland

Epilepsy, Partial epilepsy, with impairment of consciousness[EPILEPSIA GENERALISATA SECUNDARIA]

9.7

17.1

AAA20

NOMESCO Finland

Insertion of intraventricular pressure monitoring device

6.9

17.1

ICD-10 Finland

2.2

17.0

179

836

SPAT1297

SPAT

Other function in accordance with speech therapy nomenclature

7.1

17.0

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

0.8

16.8

1491

18170

W06

ICD-10 Finland

Fall involving bed

3.6

16.8

208

4019X

ICD-9 Finland

Essential hypertension, Unspecified

1.9

16.8

267

1461

G00.9

ICD-10 Finland

Bacterial meningitis, unspecified

8.4

16.6

YJA10

NOMESCO Finland

Excision of liver from cadaver donor

170.2

16.5

G41.2

ICD-10 Finland

Complex partial status epilepticus

13.4

16.4

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

2.2

16.2

162

736

R11

ICD-10 Finland

Nausea and vomiting

1.6

16.2

467

3044

F10.25

ICD-10 Finland

Alcohol dependence continuous use

2.8

16.0

101

360

P15

ICPC

Chronic alcohol abuse

2.3

15.9

145

634

G40.09

ICD-10 Finland

Other or unspecified partial (focal) idiopathic epilepsy or epileptic syndrome with local onset

6.0

15.8

TK800

NOMESCO Finland

Hemodialysis

2.3

15.6

143

627

4341A

ICD-9 Finland

Occlusion of cerebral arteries, Cerebral embolism

+∞

15.6

4331X

ICD-9 Finland

Occlusion and stenosis of precerebral arteries, Carotid artery[OCCL/STENOSIS ARTERIAE CAROTIS SINE INFARCTU CEREBR]

+∞

15.6

YFA50

NOMESCO Finland

Excision of heart for preparation of homograft

+∞

15.6

74789

ICD-8 Finland

Other congenital anomalies of circulatory system, Other specified anomalies of circulatory system

85.2

15.5

R40.2

ICD-10 Finland

Coma, unspecified

3.2

15.5

249

PA7KT

NOMESCO Finland

Temporary closure of brain artery

160.2

15.5

PA2AG

NOMESCO Finland

Restrected MRI examination of vessels in the head with high intensity magnet

13.7

15.4

RP120

NOMESCO Finland

38.1

15.4

AA1AG

NOMESCO Finland

Short MRI examination of brain with median intensity magnet

3.5

15.3

199

AAB10

NOMESCO Finland

Partial excision of intracranial lesion

3.4

15.3

210

F80.1

ICD-10 Finland

Expressive language disorder

5.1

15.2

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

2.5

15.1

117

468

G45.0

ICD-10 Finland

Vertebro-basilar artery syndrome

2.2

15.0

159

743

N29

ICPC

Neurological sympt/complt other

2.4

15.0

129

545

R01AD12

ATC

fluticasone furoate; nasal

0.7

14.9

843

10906

G40.11

ICD-10 Finland

Simple partial epileptic seizure that develops into a complex partial seizure

9.4

14.9

Q61.2

ICD-10 Finland

Polycystic kidney, autosomal dominant

4.6

14.8

112

S42.2

ICD-10 Finland

Fracture of upper end of humerus

1.7

14.8

304

1808

Z94.0

ICD-10 Finland

Kidney transplant status

3.4

14.6

212

G41.0

ICD-10 Finland

Grand mal status epilepticus

9.1

14.6

WYA20

NOMESCO Finland

Home visit

2.3

14.6

133

582

4331A

ICD-9 Finland

Occlusion and stenosis of precerebral arteries, Carotid artery[OCCL/STENOSIS ARTERIAE CAROTIS CUM INFARCTU CEREBRI]

+∞

14.6

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.3

14.5

1236

9830

SPAT1251

SPAT

Organisation of medication

1.8

14.5

268

1546

R1250

NOMESCO Finland

Evaluation of functional capability

2.3

14.5

130

565

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.2

14.5

2925

25725

PA2HT

NOMESCO Finland

Extensive embolisation of arterio-venous malformation of the brain

36.0

14.4

EBA15

NOMESCO Finland

Extraction of large number of teeth

1.9

14.3

221

1204

TAA40

NOMESCO Finland

Cathetrisation of cerebrospinal fluid through skin

7.1

14.2

A29

ICPC

General symptom/complaint other

1.4

14.2

694

5054

L04AA06

ATC

mycophenolic acid; systemic

2.7

14.2

347

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.4

14.2

594

4199

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.3

14.2

1792

14978

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

1.4

14.1

596

4218

RS313

NOMESCO Finland

5.3

14.1

A10AE04

ATC

insulin glargine; parenteral

1.5

14.1

551

3843

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.4

14.1

679

4929

7803A

ICD-9 Finland

General symptoms, Convulsions

3.8

14.0

157

N05BA04

ATC

oxazepam; oral

1.3

13.9

1501

12310

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.3

13.9

1632

13519

127

Kela drug reimbursment

Transplant complication

2.8

13.8

305

WX408

NOMESCO Finland

General anesthesy, balanced

1.3

13.8

1572

12976

7840A

ICD-9 Finland

Symptoms involving head and neck, Headache

3.1

13.6

241

PA2JT

NOMESCO Finland

Very extensive embolisation of arterio-venous malformation of the brain

75.2

13.6

43300

ICD-8 Finland

Cerebral thrombosis, Wtih hypertension (benign)

+∞

13.5

43198

ICD-8 Finland

Cerebral haemorrhage, Aliandefinita, hypertonia non indicata

+∞

13.5

OAB43

SPAT

0.6

13.5

187

3154

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.2

13.4

140

652

H43.1

ICD-10 Finland

Vitreous haemorrhage

2.1

13.4

152

734

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.4

13.3

774

5804

F10.24

ICD-10 Finland

Alcohol depence active use

2.9

13.3

287

3451A

ICD-9 Finland

Epilepsy, Generalised convulsive epilepsy

6.4

13.3

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

1.5

13.1

477

3277

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

3.6

13.1

157

ZSA00

NOMESCO Finland

Procedure related to previous procedure classified in chapter A

5.6

13.1

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

2.1

13.0

149

723

N05CF01

ATC

zopiclone; oral

1.2

13.0

2238

19322

G40.00

ICD-10 Finland

Benign childhood epilepsy with centrotemporal EEG spikes

8.7

12.9

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

2.7

12.8

321

APM

Auricle closure

50.0

12.8

C08CA13

ATC

lercanidipine; oral

1.3

12.8

877

6751

G03.9

ICD-10 Finland

Meningitis, unspecified

6.9

12.8

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

1.9

12.8

178

933

R4120

SPAT

8.0

12.8

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

4.2

12.7

112

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

0.8

12.7

1771

20656

F03

ICD-10 Finland

Unspecified dementia

1.5

12.6

370

2426

I95.1

ICD-10 Finland

Orthostatic hypotension

1.7

12.5

246

1448

4349A

ICD-9 Finland

Occlusion of cerebral arteries, Cerebral artery occlusion, unspecified[OCCL/STENOS ARTER.CEREBRALES NUD CUM INFARCTU CEREB]

+∞

12.5

43008

ICD-8 Finland

Subarachnoid haemorrhage, Alii definiti, cum hypertonia

+∞

12.5

2164

FHL

Crotigree

+∞

12.5

C08DB01

ATC

diltiazem; oral

1.5

12.5

449

3080

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.2

12.5

126

581

AAG50

NOMESCO Finland

Stereotactic intracranial radiotherapy

4.4

12.4

101

J01EA01

ATC

trimethoprim; systemic

1.2

12.3

1599

13375

N03AE01

ATC

clonazepam; systemic

1.6

12.3

320

2037

XX3DW

NOMESCO Finland

Time consuming IT work

1.4

12.3

583

4222

K89

ICPC

Transient cerebral ischaemia

3.3

12.3

182

G44.8

ICD-10 Finland

Other specified headache syndromes

3.3

12.2

177

Z43.0

ICD-10 Finland

Attention to tracheostomy

8.4

12.2

R50.9

ICD-10 Finland

Fever, unspecified

1.3

12.2

811

6212

AA9PW

NOMESCO Finland

37.5

12.2

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.4

12.1

652

4828

R13

ICD-10 Finland

Dysphagia

1.5

12.0

371

2462

R47.8

ICD-10 Finland

Other and unspecified speech disturbances

3.5

12.0

159

Z49.1

ICD-10 Finland

Extracorporeal dialysis

2.5

11.9

367

G40.6

ICD-10 Finland

Grand mal seizures, unspecified (with or without petit mal)

4.7

11.9

2127

FHL

Ventriculostomy

46.7

11.9

W17

ICD-10 Finland

Other fall from one level to another

1.7

11.8

225

1314

J01CF02

ATC

cloxacillin; systemic

1.9

11.8

158

820

A04

ICPC

Weakness/tiredness general

1.3

11.7

767

5861

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.5

11.7

458

3192

M01AE01

ATC

ibuprofen; systemic, rectal

0.8

11.7

5275

55773

A12AA04

ATC

calcium carbonate; oral

2.3

11.7

102

441

G30.8

ICD-10 Finland

Other Alzheimer disease

1.9

11.7

171

916

N03AX23

ATC

brivaracetam; systemic

16.4

11.6

Z02.7

ICD-10 Finland

Issue of medical certificate

1.6

11.6

339

2217

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

2.9

11.6

246

AAK85

NOMESCO Finland

Replantation of previously excised part of skull cap

65.0

11.6

NK6AI

NOMESCO Finland

Other cone beam scan

18.9

11.6

C09CA06

ATC

candesartan; oral

1.3

11.5

1248

10215

G942, I615

ICD-10 Finland

+∞

11.5

4360A

ICD-9 Finland

Acute but ill-defined cerebrovascular disease[MORBUS CEREBROVASCULARIS ACUTUS NON DEFINITUS]

+∞

11.5

L82

ICD-10 Finland

Seborrhoeic keratosis

0.7

11.4

564

7450

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

1.6

11.4

315

2038

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

2.8

11.2

257

SPAT1276

SPAT

Outlining of treatment with patient or their family members

1.9

11.2

161

855

N01

ICPC

Headache

1.5

11.2

370

2494

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

2.7

11.0

284

L57.0

ICD-10 Finland

Actinic keratosis

0.7

11.0

403

5575

A11CC03

ATC

alfacalcidol; systemic

2.0

11.0

143

735

SPAT1240

SPAT

Therapeutic discussion

1.5

11.0

384

2621

A86

ICD-10 Finland

Unspecified viral encephalitis

4.4

11.0

RT152

NOMESCO Finland

43.3

10.9

2102

FHL

Exploratory craniotomy and / or cranectomy

43.3

10.9

F10.20

ICD-10 Finland

Alcohol dependence currently independent

2.2

10.9

102

457

SPAT1100

SPAT

Long-term monitoring of blood pressure

1.4

10.8

481

3444

S82

ICPC

Naevus/mole

0.7

10.8

340

4828

F05.8

ICD-10 Finland

Other delirium

3.1

10.8

179

N03AX15

ATC

zonisamide; oral

10.5

10.7

5541

FHL

Subclavia and / or carotid endarterectomy, reconstruction or bypass surgery

17.8

10.7

PA2GT

NOMESCO Finland

Embolisation of arterio-venous malformation of the brain

60.0

10.6

N02AA05

ATC

oxycodone; systemic

1.3

10.6

1014

8171

RS340

NOMESCO Finland

6.0

10.5

C09CA01

ATC

losartan; oral

1.2

10.5

1537

12998

N03AX16

ATC

pregabalin; oral

1.2

10.4

1347

11241

N30.9

ICD-10 Finland

Cystitis, unspecified

1.5

10.4

324

2154

I63.6

ICD-10 Finland

Cerebral infarction due to cerebral venous thrombosis, nonpyogenic

+∞

10.4

G942, I601

ICD-10 Finland

+∞

10.4

F06.9

ICD-10 Finland

Unspecified mental disorder due to brain damage and dysfunction and to physical disease

5.2

10.4

F10.09

ICD-10 Finland

Alcohol intoxication UNS

2.2

10.3

101

461

Z03

ICPC

Housing/neighbourhood problem

3.5

10.3

136

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.4

10.3

575

4281

G91.3

ICD-10 Finland

Post-traumatic hydrocephalus, unspecified

12.0

10.3

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

3.0

10.3

200

SPAT1301

SPAT

No procedures

1.2

10.2

2009

17486

2BD01

NOMESCO Finland

5.3

10.2

F10.01

ICD-10 Finland

Alcohol-related acute intoxication with permanent or other somatic damage

3.8

10.2

112

Z25.8

ICD-10 Finland

Need for immunization against other specified single viral diseases

0.7

10.2

295

4246

E78.00

ICD-10 Finland

Familial hypercholesterolaemia

1.6

10.1

246

1540

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

0.7

10.1

532

6972

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.3

10.1

1149

9451

WW804

NOMESCO Finland

Transfer from treating institution to higher-Level care, accompanied by doctor

6.9

10.0

R20.2

ICD-10 Finland

Paraesthesia of skin

1.6

10.0

277

1793

AAF99

NOMESCO Finland

Other shunt operation on ventricle of brain or intracerebral cyst

6.4

10.0

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.2

10.0

1851

16021

G81

ICD-10 Finland

Hemiplegia

40.1

10.0

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

3.0

9.9

179

X58

ICD-10 Finland

Exposure to other specified factors

1.3

9.9

657

5034

G81.0

ICD-10 Finland

Flaccid hemiplegia

16.7

9.9

N06AX16

ATC

venlafaxine; oral

1.4

9.8

567

4246

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

1.5

9.8

341

2326

F07.9

ICD-10 Finland

Unspecified organic personality and behavioural disorder due to brain disease, damage and dysfunction

8.7

9.7

E87.6

ICD-10 Finland

Hypokalaemia

1.7

9.7

184

1075

SPAT1042

SPAT

Guidance concerning balance maintenance

3.3

9.5

140

3AX01

NOMESCO Finland

4.8

9.5

ZXA00

NOMESCO Finland

Right side

1.2

9.5

1789

15492

XX9BW

NOMESCO Finland

Submitting image material and/or investigation material to authority or other institution

2.6

9.5

264

L01AX03

ATC

temozolomide; systemic

3.4

9.5

130

R33

ICD-10 Finland

Retention of urine

1.3

9.5

572

4316

K91

ICD-10 Finland

Postprocedural disorders of digestive system, not elsewhere classified

100.1

9.4

G31.2

ICD-10 Finland

Degeneration of nervous system due to alcohol

3.1

9.4

158

C02EA02

ATC

1.5

9.4

354

2453

I65.1

ICD-10 Finland

Occlusion and stenosis of basilar artery

+∞

9.4

I65.3

ICD-10 Finland

Occlusion and stenosis of multiple and bilateral precerebral arteries

+∞

9.4

WW805

NOMESCO Finland

Transfer from treating institution to lower-Level care, accompanied by paramedic/nurse

12.3

9.3

H53.1

ICD-10 Finland

Subjective visual disturbances

1.5

9.3

281

1858

F01.19

ICD-10 Finland

Multi-infarct dementia without information on additional symptoms

5.5

9.3

JN5BD

NOMESCO Finland

Head and body CT examination for trauma

3.0

9.3

165

D43.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Brain, supratentorial

3.5

9.3

122

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.6

9.2

238

1514

S00.0

ICD-10 Finland

Superficial injury of scalp

1.9

9.2

127

671

R2120

NOMESCO Finland

Counselling and guidance concerning rehabilitation services and social security

2.9

9.2

189

S72.0

ICD-10 Finland

Fracture of neck of femur

1.5

9.1

302

2039

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

1.6

9.0

220

1381

S22.3

ICD-10 Finland

Fracture of rib

1.4

9.0

372

2624

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.4

9.0

426

3083

SPAT1101

SPAT

Orthostatic test

1.5

9.0

312

2128

G46.7*I67.9

ICD-10 Finland

Other lacunar syndromes

36.7

9.0

XA800

SPAT

36.7

9.0

G41.8

ICD-10 Finland

Other status epilepticus

10.0

9.0

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

1.4

9.0

354

2479

103

Kela drug reimbursment

Diabetes, insulin-treated

1.2

8.9

1798

15652

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.5

8.9

281

1877

R90.8

ICD-10 Finland

Other abnormal findings on diagnostic imaging of central nervous system

3.0

8.9

165

-2

ICPC

2.8

8.8

188

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.2

8.8

1122

9335

M05BA04

ATC

alendronic acid; oral

1.3

8.8

563

4284

RS222

NOMESCO Finland

2.3

8.8

343

C07AG02

ATC

carvedilol; oral

1.4

8.8

398

2861

C02CA01

ATC

prazosin; oral

1.8

8.8

135

739

L89

ICD-10 Finland

Decubitus ulcer and pressure area

1.9

8.8

115

596

V03AE02

ATC

sevelamer; oral

3.7

8.8

I65.9

ICD-10 Finland

Occlusion and stenosis of unspecified precerebral artery

50.0

8.7

A10AE05

ATC

insulin detemir; parenteral

1.5

8.7

287

1941

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

1.9

8.6

122

650

K78

ICPC

Atrial fibrillation/flutter

1.3

8.6

539

4092

C07AB03

ATC

atenolol; systemic

1.4

8.6

428

3130

Z75.0

ICD-10 Finland

Medical services not available in home

5.0

8.6

PA7CC

NOMESCO Finland

Very extensive angiography of arteries of neck and brain

16.3

8.5

34400

ICD-8 Finland

Other cerebral paralysis, Hemiplegia NUD

6.9

8.5

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

2.2

8.5

360

SPAT1293

SPAT

Other function in accordance with rehabilitation guidance nomenclature

3.0

8.5

148

3314A

ICD-9 Finland

Other cerebral degenerations, Obstructive hydrocephalus

27.5

8.5

J69.1

ICD-10 Finland

Pneumonitis due to oils and essences

27.5

8.5

RT151

NOMESCO Finland

27.5

8.5

PA2BM

NOMESCO Finland

MRI examination of vessels in the head with 3 Tesla magnet

20.0

8.5

3459X

ICD-9 Finland

Epilepsy, unspecified

4.5

8.4

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

1.6

8.4

228

1473

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

2.5

8.4

248

AAC20

NOMESCO Finland

Anastomosis to intracranial vessel

90.1

8.4

S01.9

ICD-10 Finland

Open wound of head, part unspecified

2.0

8.4

101

506

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

2.4

8.4

275

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

0.8

8.3

556

7063

M01AB05

ATC

diclofenac; systemic, rectal

0.9

8.3

3574

38455

PCU93

NOMESCO Finland

Injection of therapeutic or sclerosing agent into bypass from suprarenal abdominal aorta and visceral arteries

+∞

8.3

AAC10

NOMESCO Finland

Reinforcement of intracranial aneurysm wall

+∞

8.3

SPAT1053

SPAT

Memory test

1.2

8.3

1110

9280

RS230

NOMESCO Finland

3.6

8.3

Q61.3

ICD-10 Finland

Polycystic kidney, unspecified

3.8

8.3

U04

ICPC

Incontinence urine

1.5

8.2

277

1877

F43.29

ICD-10 Finland

Adaptation disorder UNS

2.3

8.1

295

N99

ICPC

Neurological disease other

2.3

8.1

324

8000/3-C34.9

ICD-O-3

Neoplasm, malignant of lung, NOS

0.3

8.1

593

RS314

NOMESCO Finland

7.5

8.1

R01AD08

ATC

fluticasone; nasal

0.8

8.1

1047

12377

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

1.6

8.1

179

1099

PA5AC

NOMESCO Finland

Angiography of arteries to the face with X-ray

33.3

8.1

PA7ST

NOMESCO Finland

Extensive medical infusion to cerebral artery

33.3

8.1

RS390

NOMESCO Finland

17.1

8.1

PA6AM

NOMESCO Finland

Simple MRI examination of neck vasculature with 3 Tesla magnet

11.7

8.1

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.3

8.1

836

6797

ZXF05

NOMESCO Finland

Interruption of procedure for other patient related reason

3.4

8.0

110

Z72.1

ICD-10 Finland

Alcohol use

2.4

8.0

280

AWB00

NOMESCO Finland

Reoperation for superficial infection in surgery of the nervous system

6.8

8.0

RT162

NOMESCO Finland

22.0

8.0

P70

ICPC

Dementia

1.7

8.0

154

909

H35.6

ICD-10 Finland

Retinal haemorrhage

2.8

8.0

172

SDA03

NOMESCO Finland

Demanding parodonthologic therapy

0.8

7.9

1357

15640

R23.8

ICD-10 Finland

Other and unspecified skin changes

0.8

7.9

576

7236

TJD20

NOMESCO Finland

Change of gastrostomy tube

3.8

7.9

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

3.6

7.9

G93.6

ICD-10 Finland

Cerebral oedema

13.0

7.9

RF420

NOMESCO Finland

2.2

7.9

328

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.2

7.9

1818

15994

R60.0

ICD-10 Finland

Localized oedema

1.3

7.8

670

5315

2152

FHL

Extraction, big brain

6.1

7.8

R99

ICD-10 Finland

Other ill-defined and unspecified causes of mortality

1.8

7.8

121

665

S02.30

ICD-10 Finland

Fracture of orbital floor, closed

2.7

7.8

185

F06.7

ICD-10 Finland

Mild cognitive disorder

1.7

7.8

169

1030

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

1.8

7.8

132

749

ZXM40

NOMESCO Finland

Use of fluorescent substance

9.4

7.8

Z51.5

ICD-10 Finland

Palliative care

1.4

7.8

398

2928

OAB48

SPAT

0.6

7.7

1472

RF120

NOMESCO Finland

2.4

7.7

273

SPAT1244

SPAT

Occupational therapy

2.3

7.7

281

NG4AA

NOMESCO Finland

Lower leg X-ray examination

1.8

7.7

132

753

2213

FHL

Hematoma removal, intracerebral or cerebral palsy reversion

45.0

7.7

AAK99

NOMESCO Finland

Other operation on skull or dura

45.0

7.7

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.3

7.7

649

5141

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

1.9

7.7

100

518

B01AB05

ATC

enoxaparin; parenteral

1.2

7.7

1856

16388

T74.1

ICD-10 Finland

Physical abuse

2.4

7.6

238

Z01.2

ICD-10 Finland

Dental examination

0.9

7.6

1587

18010

SDA04

NOMESCO Finland

Very demanding parodonthologic therapy

0.8

7.6

760

9217

L15

ICPC

Knee symptom/complaint

0.8

7.6

799

9642

2130

FHL

Ventricular atrial shunt

25.0

7.6

I66.9

ICD-10 Finland

Occlusion and stenosis of unspecified cerebral artery

25.0

7.6

J01DA01

ATC

[U] cefalexin; systemic

1.1

7.6

4052

37869

PA6BG

NOMESCO Finland

MRI examination of neck vasculature with high intensity magnet

4.2

7.6

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

1.5

7.5

283

1968

OAB95

SPAT

0.4

7.5

800

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

1.7

7.5

155

935

D32.00

ICD-10 Finland

Benign tumor of the meninges on the outer surface of the cerebrum

2.1

7.5

357

WW200

SPAT

1.3

7.5

469

3565

S70.0

ICD-10 Finland

Contusion of hip

1.5

7.5

217

1424

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.4

7.5

338

2432

79199

ICD-8 Finland

Headache

2.0

7.4

469

R74

ICPC

Upper respiratory infection acute

0.8

7.4

770

9309

S09.9

ICD-10 Finland

Unspecified injury of head

2.3

7.4

274

I66.0

ICD-10 Finland

Occlusion and stenosis of middle cerebral artery

80.1

7.4

WX320

NOMESCO Finland

Spinalanesthesy

0.8

7.4

999

11768

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.2

7.4

792

6461

OAA80

SPAT

0.4

7.4

855

XX1ZW

NOMESCO Finland

Very extensive written report from radiologist

4.2

7.4

L04AD01

ATC

ciclosporin; systemic

2.1

7.4

375

K99

ICPC

Cardiovascular disease other

1.6

7.3

166

1025

S72.1

ICD-10 Finland

Pertrochanteric fracture

1.6

7.3

166

1028

N03AX12

ATC

gabapentin; oral

1.2

7.3

800

6546

G942, I600

ICD-10 Finland

+∞

7.3

G942, I690

ICD-10 Finland

+∞

7.3

G942, I609

ICD-10 Finland

+∞

7.3

I67.5

ICD-10 Finland

Moyamoya disease

+∞

7.3

43191

ICD-8 Finland

Cerebral haemorrhage, Subduralis non traumatica, hypertonia non indicata

+∞

7.3

YA1AD

NOMESCO Finland

CT examination of head and neck for dose design of radiotherapy

2.6

7.3

200

C02DE04

ATC

1.5

7.2

225

1506

4351A

ICD-9 Finland

Transient cerebral ischaemia, Vertebral artery syndrome

3.7

7.2

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

0.7

7.2

175

2597

FP1B5

NOMESCO Finland

Resting ECG, 12 leads

2.0

7.2

411

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.4

7.2

287

2021

Z00.0

ICD-10 Finland

General medical examination

1.2

7.2

1026

8635

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.2

7.2

765

6238

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

2.6

7.1

195

44209

ICD-8 Finland

Other aneurysm, Ruptura non indicata

30.0

7.1

AAF10

NOMESCO Finland

Lumboperitoneal shunt

20.0

7.1

ZX120

NOMESCO Finland

Intravenous

1.3

7.1

520

4041

SPAT1139

SPAT

Nutrition survey

1.6

7.1

180

1147

F21

ICPC

2.2

7.1

301

S22.4

ICD-10 Finland

Multiple fractures of ribs

1.8

7.0

122

700

U07.2

ICD-10 Finland

COVID-19, virus not identified

0.7

7.0

250

3470

Z98.2

ICD-10 Finland

Presence of cerebrospinal fluid drainage device

10.0

7.0

ZXC50

NOMESCO Finland

Cryotherapy

0.6

7.0

1366

40199

ICD-8 Finland

Essential benign hypertension

1.6

7.0

153

940

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

2.6

7.0

192

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

2.0

7.0

412

R01AD09

ATC

mometasone; nasal

0.9

7.0

1862

20760

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

2.0

6.9

405

E87.0

ICD-10 Finland

Hyperosmolality and hypernatraemia

3.2

6.9

108

R1100

NOMESCO Finland

General evaluation of the need for rehabilitation

2.7

6.9

170

ZXC95

NOMESCO Finland

Use of surgical navigator

2.3

6.9

250

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.4

6.8

325

2361

RF220

NOMESCO Finland

2.0

6.8

422

N05CD07

ATC

temazepam; oral

1.2

6.8

884

7363

N06AX05

ATC

trazodone; oral

1.8

6.8

107

597

R41.3

ICD-10 Finland

Other amnesia

1.6

6.8

161

1012

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

2.1

6.8

353

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

1.7

6.8

127

749

G93.5

ICD-10 Finland

Compression of brain

39.9

6.7

RS130

NOMESCO Finland

6.1

6.7

E85.4

ICD-10 Finland

Organ-limited amyloidosis

5.6

6.7

RL110

NOMESCO Finland

16.7

6.7

RS220

NOMESCO Finland

2.2

6.7

287

I33.0

ICD-10 Finland

Acute and subacute infective endocarditis

2.7

6.7

156

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.4

6.7

330

2413

N06AA09

ATC

amitriptyline; systemic

1.3

6.7

540

4257

3792A

ICD-9 Finland

Other disorders of eye, Disorders of vitreous body

7.1

6.7

Z50.1

ICD-10 Finland

Other physical therapy

1.4

6.7

297

2136

7804A

ICD-9 Finland

General symptoms, Dizziness and giddiness

1.9

6.7

519

PA2CD

NOMESCO Finland

Very extensive CT angiography of brain arteries

22.5

6.7

A10AB01

ATC

insulin (human); parenteral (insulins and analog. for injection, fast-acting)

1.6

6.7

158

993

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.2

6.6

873

7287

A10BB01

ATC

glibenclamide; oral

1.4

6.6

336

2474

PA2DG

NOMESCO Finland

Very extensive MRI examination of vessels in the head with high intensity magnet

12.2

6.6

RL130

NOMESCO Finland

4.6

6.6

F01.0

ICD-10 Finland

Vascular dementia of acute onset

4.6

6.6

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

2.1

6.5

331

OAA67

SPAT

0.6

6.5

1445

N05AD01

ATC

haloperidol; systemic

1.5

6.5

200

1334

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

1.8

6.5

106

596

N06DA04

ATC

galantamine; oral

1.6

6.5

143

881

F00.20

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms

2.1

6.5

311

Y94.0

ICD-10 Finland

Accident at home

1.8

6.5

102

567

M17.1

ICD-10 Finland

Other primary gonarthrosis

0.8

6.5

979

11425

D68.8

ICD-10 Finland

Other specified coagulation defects

2.6

6.5

165

M05BB03

ATC

alendronic acid and colecalciferol; oral

1.6

6.5

151

945

K59.09

ICD-10 Finland

Constipation, unspecified

1.4

6.5

345

2558

F10.49

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without information about seizures

2.8

6.5

142

742

NOMESCO Finland

3.9

6.4

G40.4

ICD-10 Finland

Other generalized epilepsy and epileptic syndromes

6.2

6.4

C02DE03

ATC

69.8

6.4

ZX124

NOMESCO Finland

Perfusion of a organ or target

69.8

6.4

J63.3

ICD-10 Finland

Graphite fibrosis (of lung)

69.8

6.4

S00.9

ICD-10 Finland

Superficial injury of head, part unspecified

2.2

6.4

260

I71.4

ICD-10 Finland

Abdominal aortic aneurysm, without mention of rupture

1.5

6.4

179

1170

L76

ICPC

Fracture: other

1.6

6.4

155

978

F01

ICD-10 Finland

Vascular dementia

3.2

6.4

F05.0

ICD-10 Finland

Delirium not superimposed on dementia, so described

3.4

6.4

A01

ICPC

Pain general/multiple sites

1.3

6.4

391

2966

TGB20

NOMESCO Finland

Tracheostomy tube replacement

8.1

6.3

F01.8

ICD-10 Finland

Other vascular dementia

8.1

6.3

34599

ICD-8 Finland

Epilepsy, Other and unspecified

3.0

6.3

110

Angiography of the heart and coronary arteries

1.3

6.3

474

3702

SPAT1279

SPAT

Preparation of immediate hospitalisation

1.9

6.3

409

G40.0

ICD-10 Finland

Localization-related (focal)(partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset

11.0

6.3

F06.8

ICD-10 Finland

Other specified mental disorders due to brain damage and dysfunction and to physical disease

5.9

6.3

G40.51

ICD-10 Finland

Epileptic seizures related to alcohol

5.5

6.3

N06AX21

ATC

duloxetine; oral

1.3

6.3

462

3597

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

1.7

6.3

129

782

ZX114

NOMESCO Finland

Intramuscular

2.0

6.3

360

AAC30

NOMESCO Finland

Intracranial occlusion of vascular fistula

+∞

6.2

PA2AT

NOMESCO Finland

Cerebral artery PTA

+∞

6.2

PA2BT

NOMESCO Finland

Cerebral artery extensive PTA

+∞

6.2

Y3090

ICD-8 Finland

+∞

6.2

G942, I606

ICD-10 Finland

+∞

6.2

PA7YT

NOMESCO Finland

Very extensive carotis artery PTA with stent

+∞

6.2

2163

FHL

Proxies. Vascular ligation, big brain

+∞

6.2

I67.7

ICD-10 Finland

Cerebral arteritis, not elsewhere classified

+∞

6.2

G40.39

ICD-10 Finland

Other or unspecified generalized epileptic syndromes with atonic, clonic, myoclonic or tonic-clonic seizures

3.7

6.2

G46.4

ICD-10 Finland

Cerebellar stroke syndrome

26.7

6.2

7478X

ICD-9 Finland

Other congenital anomalies of circulatory system, Other specified anomalies of circulatory system

26.7

6.2

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.2

6.2

1039

8873

Z08

ICPC

Social welfare problem

2.1

6.2

293

J01FA09

ATC

clarithromycin; systemic

0.9

6.2

1256

14306

JA1AE

NOMESCO Finland

Ultrasound examination of groin and abdominal wall

1.8

6.1

522

F10.06

ICD-10 Finland

Alcohol-related acute intoxication with seizures

7.7

6.1

ZX122

NOMESCO Finland

Intra-arterial

3.1

6.1

P29

ICPC

Psychological sympt/compl other

1.5

6.1

174

1146

G72.8

ICD-10 Finland

Other specified myopathies

1.8

6.1

484

LAF11

NOMESCO Finland

Laparoscopic bilateral salpingo-oophorectomy

0.6

6.1

1482

C09AA04

ATC

perindopril; oral

1.4

6.1

307

2258

C03BA11

ATC

indapamide; oral

1.5

6.1

178

1177

J96.0

ICD-10 Finland

Acute respiratory failure

1.9

6.1

442

Z71.8

ICD-10 Finland

Other specified counselling

1.2

6.1

1113

9585

PBL09

NOMESCO Finland

Construction of arteriovenous fistula from brachial artery

3.7

6.0

F01.30

ICD-10 Finland

Mixed cortical and subcortical vascular dementia without additional symptoms

3.7

6.0

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

0.9

6.0

1921

21207

K92.0

ICD-10 Finland

Haematemesis

1.6

6.0

148

937

AXX01

SPAT

2.0

6.0

364

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

2.2

6.0

248

L13

ICPC

Hip symptom/complaint

0.8

6.0

629

7598

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

1.9

6.0

392

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

3675

20375

2.37

322.13

2.7

2.0

u/l

254.2

230.4

0.35

3530

18780

(3018677) aPTT in Platelet poor plasma by Coagulation assay

2459

9703

3.12

307.65

2.4

1.9

29.2

30.2

11.58

2401

9381

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

382

469

8.46

289.62

3.3

1.3

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

292

332

9.06

235.08

2.1

—

(3036489) Thrombin time

664

1812

3.88

210.71

2.3

2.0

21.0

22.0

4.13

618

1583

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

492

1094

4.70

204.60

2.8

1.3

e6/l

69.2

26.3

3.15

407

840

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

492

1094

4.70

204.60

2.8

1.4

e6/l

20054.0

940.1

1.88

411

892

(3044290) Cell count panel - Cerebral spinal fluid

448

991

4.71

187.30

2.9

1.3

—

(3003396) Base excess in Arterial blood by calculation

1697

8655

2.19

163.33

10.0

6.6

mmol/l

1.4

1.1

2.17

1330

6663

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1697

8684

2.18

161.81

10.1

6.6

kpa

5.1

0.01

1621

8221

(3027801) Oxygen [Partial pressure] in Arterial blood

1695

8682

2.18

161.16

10.1

6.6

kpa

12.7

11.9

5.49

1622

8213

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

483

1269

3.97

160.97

2.0

1.3

mg/l

820.1

562.4

1.91

459

1192

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

200

251

8.13

148.48

4.0

1.2

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

2016

11444

1.98

143.26

3.4

3.1

mmol/l

0.8

2.13

1870

10545

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

167

180

9.43

139.83

2.4

2.3

umol/l

54.2

56.8

0.36

127

137

(3016018) Differential panel - Cerebral spinal fluid

268

503

5.46

135.28

3.4

1.2

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

309

709

4.48

123.03

3.7

4.7

umol/l

346.4

348.7

0.09

256

605

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

399

1109

3.72

122.32

1.8

1.2

mmol/l

3.8

0.14

369

1033

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

152

183

8.43

116.72

3.3

2.9

umol/l

30.9

28.5

1.41

122

137

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1665

9482

1.93

114.10

6.1

5.4

mmol/l

1.0

7.10

1542

8683

(3016502) Oxygen saturation in Arterial blood

1440

7806

2.01

113.90

11.0

6.9

95.9

95.4

2.26

1385

7475

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1335

7079

2.04

112.17

11.6

7.3

g/l

121.3

120.1

1.33

1299

6811

(3014576) Chloride [Moles/volume] in Serum or Plasma

1637

9357

1.92

110.57

8.5

6.5

mmol/l

104.6

104.3

1.62

1596

9149

(3023410) Appearance of Cerebral spinal fluid

226

454

5.08

105.62

3.7

1.4

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

475

1681

2.93

98.00

2.9

2.3

g/l

3.6

0.21

458

1588

(3020779) Urea [Moles/volume] in Serum or Plasma

1239

6726

1.98

96.33

7.6

6.6

mmol/l

8.7

11.2

26.12

1158

6332

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

430

1457

3.05

95.82

2.9

2.3

194.7

203.9

1.20

421

1375

(3043409) Potassium [Moles/volume] in Arterial blood

571

2305

2.58

91.23

7.9

3.9

mmol/l

3.8

3.9

2.81

543

2152

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

932

4651

2.12

91.01

12.2

8.2

0.7

3.00

926

4610

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

13.39

90.28

2.0

4.2

umol/l

44.4

38.7

0.92

(3023368) Bacteria identified in Blood by Culture

2991

21283

1.61

89.66

4.7

4.3

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

929

4670

2.10

88.90

12.2

8.1

1.4

1.3

3.07

924

4633

(3008152) Bicarbonate [Moles/volume] in Arterial blood

957

4881

2.08

88.07

12.6

6.5

mmol/l

24.8

24.5

1.58

907

4539

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

190

385

5.02

87.91

2.1

1.2

mmol/l

2.8

2.1

5.26

167

360

(3019060) Gas panel - Arterial blood

999

5181

2.04

87.84

8.4

4.5

—

(3032080) INR in Blood by Coagulation assay

3969

30265

1.56

87.76

10.8

10.2

inr

1.4

1.3

0.39

1087

8251

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

24.00

86.90

2.3

1.2

53.5

21.6

2.51

(3033658) Prothrombin time (PT) actual/Normal

2447

16688

1.64

86.55

5.2

3.9

84.9

86.0

1.32

2388

16255

(3018405) Lactate [Moles/volume] in Arterial blood

628

2717

2.41

86.38

7.3

3.7

mmol/l

1.4

0.10

620

2660

(3013826) Glucose [Moles/volume] in Serum or Plasma

5081

41167

1.55

83.85

7.8

4.6

mmol/l

7.0

6.8

7.51

4854

38494

(3051593) INR in Capillary blood by Coagulation assay

147

247

6.03

83.37

3.1

18.9

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

11.52

77.44

2.2

1.2

33.5

66.4

4.55

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

424

1600

2.73

77.34

2.7

2.1

93.0

87.7

4.87

408

1499

(3020191) Ethanol [Moles/volume] in Serum or Plasma

176

391

4.57

72.93

1.5

1.3

promille

1.2

0.12

122

305

(3023183) Ammonium ion [Moles/volume] in Plasma

360

1290

2.87

72.39

2.5

2.7

umol/l

32.0

34.8

1.14

304

1065

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1182

6920

1.82

71.26

2.6

2.4

ug/l

5.8

6.9

1.63

1017

5838

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

764

3875

2.06

70.72

10.8

8.5

mmol/l

24.3

0.05

721

3559

(3020891) Body temperature

635

3053

2.16

67.56

8.2

4.5

—

(3003181) Sodium [Moles/volume] in Urine

349

1373

2.60

58.49

1.6

1.3

mmol/l

83.1

61.5

10.96

287

1090

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

135

6.72

57.07

1.1

86.4

84.9

0.12

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

136

6.67

56.68

1.1

1.3

88.6

84.3

0.31

(3022217) INR in Platelet poor plasma by Coagulation assay

1589

10689

1.59

55.79

25.2

28.6

inr

1.5

0.35

178

1472

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

773

4265

1.89

55.61

9.9

6.8

mmol/l

24.4

24.8

2.83

757

4221

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

536

2624

2.11

54.18

3.4

2.7

u/ml

0.3

0.01

323

1436

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

118

242

4.93

53.90

2.0

1.2

48.3

64.1

1.43

(3026008) Bacteria identified in Urine by Culture

2962

22924

1.44

52.20

3.8

3.4

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

4052

33181

1.41

51.75

8.9

5.8

mmol/l

1.2

38.83

3731

29616

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

3561

28552

1.41

51.19

4.7

3.9

ng/l

70.6

87.2

0.30

2910

21216

(3014111) Lactate [Moles/volume] in Serum or Plasma

1051

6512

1.70

50.80

8.9

6.3

mmol/l

1.4

0.17

1007

6237

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

506

2483

2.10

50.78

2.4

2.2

ug/l

431.8

666.2

1.13

482

2348

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

8.12

50.28

1.1

1.2

76.8

73.4

0.19

(3000991) Gas panel - Venous blood

997

6120

1.71

49.83

10.7

7.5

—

(1761868) Lipid panel - Serum or Plasma

1395

20030

0.64

49.28

3.2

3.1

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1760

12479

1.51

47.87

2.0

1.8

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

7.72

47.48

1.2

83.3

79.2

0.18

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

162

5.54

46.51

1.6

1.2

19.9

25.6

0.31

(3044640) Blood type and Crossmatch panel - Blood

2808

21897

1.41

46.00

2.7

2.5

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

744

4378

1.76

42.98

1.6

1.5

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1273

8633

1.55

41.99

1.9

1.7

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

5702

63158

0.73

41.68

4.5

mmol/l

1.4

1.5

16.70

5229

56629

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1266

8612

1.55

41.11

1.9

1.8

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

239

932

2.61

40.79

5.5

6.4

mg/l

11.2

12.2

2.47

219

849

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

5775

63777

0.73

40.79

4.5

4.6

mmol/l

4.3

4.6

47.05

5330

57632

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

4334

36747

1.35

40.61

9.5

6.5

mmol/l

1.2

23.15

3747

30620

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

2169

16537

1.41

39.15

2.6

2.4

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

5986

65567

0.73

38.35

5.1

mmol/l

2.5

2.7

45.92

5502

58929

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

5604

61980

0.74

38.18

20.3

15.3

ml/min/173m2

76.6

74.4

10.38

4815

51170

(3002032) Base excess in Venous blood by calculation

1058

7119

1.55

35.74

4.4

3.6

mmol/l

2.0

1.9

0.24

884

5752

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

5880

64373

0.74

35.56

4.7

4.9

mmol/l

6.1

2.93

5297

57294

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1057

7139

1.54

35.06

4.4

3.6

kpa

5.9

5.8

0.60

1023

6920

(40768804) Tissue Pathology biopsy report

2156

27212

0.73

35.01

2.2

—

(3012544) pH of Venous blood

1085

7391

1.53

34.58

4.4

3.6

7.4

—

(3009542) Hematocrit [Volume Fraction] of Blood

5222

57999

0.76

33.85

25.1

17.2

37.7

39.0

12.34

3210

37354

(40761535) Cells panel - Urine sediment

933

6190

1.57

33.43

3.9

3.6

—

(3024354) Oxygen [Partial pressure] in Venous blood

892

5858

1.58

33.41

3.7

3.1

kpa

4.7

4.4

2.84

858

5659

(3008295) Osmolality of Serum or Plasma

178

712

2.53

28.93

1.6

1.3

mosm/kgh2o

281.3

276.9

1.65

137

529

(3011397) Hemoglobin [Presence] in Urine by Test strip

2011

15831

1.35

28.25

4.4

3.9

—

(3019150) Specific gravity of Urine by Refractometry

1903

14857

1.36

28.22

5.0

4.4

kg/l

1.0

0.64

265

2332

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

6542

69919

0.75

27.79

12.4

10.7

u/l

26.0

25.5

0.55

6295

66759

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1838

14305

1.36

27.75

4.4

3.9

ng/l

363.0

530.5

0.99

1576

12032

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

5607

60982

0.78

25.99

4.2

4.1

mmol/l

1.3

1.98

5120

54131

(3010813) Leukocytes [#/volume] in Blood

6825

72370

0.75

25.92

32.1

23.5

e9/l

7.2

6.9

27.31

6620

69766

(3000963) Hemoglobin [Mass/volume] in Blood

6825

72368

0.75

25.89

32.3

23.6

g/l

130.6

133.7

48.29

6700

70937

(3026361) Erythrocytes [#/volume] in Blood

6824

72357

0.75

25.87

32.1

23.5

e12/l

4.3

4.4

45.78

6614

69757

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

150

4.36

25.87

1.4

1.1

—

(3024731) MCV [Entitic volume]

6824

72352

0.75

25.81

32.0

23.4

91.7

91.5

3.16

6697

70911

(3035941) MCH [Entitic mass]

6824

72349

0.75

25.77

31.9

23.4

30.5

30.4

1.66

6697

70905

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

627

4022

1.60

25.75

13.3

9.2

—

(3007461) Platelets [#/volume] in Blood

6824

72331

0.75

25.53

32.1

23.5

e9/l

244.1

242.5

1.03

6634

70022

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

560

3505

1.64

25.42

3.1

2.6

0.7

0.02

553

3354

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

275

3.37

25.40

1.1

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

704

4678

1.55

24.78

3.7

3.3

g/l

126.7

127.4

0.38

691

4563

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

569

3605

1.62

24.58

3.8

4.1

52.3

46.6

6.04

562

3556

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

180

3784

0.46

23.48

1.9

1.8

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

5696

61589

0.79

23.47

6.3

mmol/mol

41.1

40.6

2.86

5231

55772

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

3635

31547

1.26

23.18

4.6

4.2

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

594

3880

1.57

22.53

3.6

3.4

mmol/l

25.3

25.2

0.37

579

3759

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

396

2350

1.72

22.01

1.3

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1340

17192

0.74

21.89

1.6

mmol/l

1.4

1.3

1.38

1158

14141

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

291

3.04

20.65

1.1

—

(3016038) Potassium [Moles/volume] in Urine

122

491

2.50

19.71

1.2

1.1

mmol/l

30.5

35.8

1.82

102

404

(3047181) Lactate [Moles/volume] in Blood

383

2327

1.67

19.52

10.7

5.9

mmol/l

1.4

1.3

0.92

333

2055

(3010375) cycloSPORINE [Mass/volume] in Blood

229

3.25

19.42

30.7

27.2

ug/l

103.0

112.7

0.79

189

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

502

3277

1.56

19.07

2.5

1.9

ug/l

2.6

2.5

0.03

414

2856

(3018418) pH of Serum or Plasma

2561

21717

1.25

18.96

4.7

4.0

7.4

0.63

450

4110

(3026782) Osmolality of Urine

1821

14833

1.29

18.86

3.4

2.9

mosm/kgh2o

542.9

549.7

0.67

1599

12586

(3024561) Albumin [Mass/volume] in Serum or Plasma

3601

31710

1.23

18.70

5.5

4.7

g/l

33.7

34.8

21.89

3320

29101

(3007853) Bacteria identified in Skin by Aerobe culture

1075

8141

1.36

18.64

1.9

1.8

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1255

15931

0.75

18.58

3.0

3.2

ug/l

0.9

0.8

0.76

891

11143

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

149

674

2.23

18.52

1.4

1.2

u/ml

3.1

2.8

0.10

212

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

145

652

2.24

18.29

1.4

1.2

u/ml

4.3

3.8

0.21

273

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

763

5499

1.42

17.74

1.9

1.6

—

(3019309) Folate [Moles/volume] in Red Blood Cells

1908

15748

1.27

17.59

1.8

nmol/l

1220.7

1168.9

1.60

1500

11615

(3029937) Albumin [Presence] in Urine by Test strip

2187

18350

1.25

17.50

5.1

4.4

estimate

0.0

1.94

564

5894

(21494755) Public health laboratory ask at order entry panel

185

3492

0.52

17.50

1.3

1.4

—

(4034850)

356

2185

1.65

17.47

12.7

11.2

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

7.37

17.35

1.3

1.2

—

(3002385) Erythrocyte distribution width [Ratio]

4884

53021

0.82

17.24

27.2

19.5

14.0

13.9

8.02

4772

51702

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

2404

27954

0.81

16.97

4.7

5.3

ug/l

7.9

4.0

0.66

2134

24775

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

489

3280

1.52

16.43

8.5

4.9

1.7

1.6

1.02

456

3077

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

113

2460

0.45

16.25

1.5

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1181

9246

1.32

16.24

10.2

7.9

—

(3031040) Bacteria [#/volume] in Urine by Automated count

5029

46141

1.21

16.18

5.8

4.9

e6/l

1771.6

1787.7

0.01

770

(3039000) Anion gap in Blood

283

1686

1.70

15.58

12.4

6.7

mmol/l

11.1

11.3

0.27

254

1505

(3018572) Chloride [Moles/volume] in Blood

283

1687

1.70

15.55

12.4

6.7

mmol/l

105.3

105.0

0.46

254

1506

(3007930) Methemoglobin/Hemoglobin.total in Blood

478

3234

1.50

15.42

8.6

4.9

0.9

1.88

446

3032

(3042936) Bacteria identified in Isolate by Culture

1269

10113

1.30

15.24

2.2

2.0

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

502

3469

1.47

14.59

5.1

3.8

mmol/l

24.2

24.1

0.24

458

3102

(3036481) Cortisol [Moles/volume] in Serum or Plasma

755

5625

1.37

14.38

2.1

2.3

nmol/l

378.0

377.2

0.04

687

5126

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

232

2.86

14.03

1.6

2.1

umol/l

74.0

144.9

1.80

128

(4198724)

126

3.58

13.89

1.5

1.4

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

5635

59852

0.84

13.43

4.7

mu/l

2.0

2.1

2.33

5133

53414

(3015235) Bicarbonate [Moles/volume] in Capillary blood

312

1990

1.59

13.17

3.6

3.1

mmol/l

24.5

24.9

0.95

273

1732

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

630

4627

1.39

13.09

4.3

3.5

mmol/l

1.9

2.0

0.25

444

3408

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

657

4859

1.38

13.08

4.4

3.6

kpa

5.2

0.25

596

4437

(3009343) pH of Capillary blood

649

4793

1.38

13.04

4.4

3.6

7.4

1.02

604

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

125

613

2.05

12.78

1.2

1.1

118.0

115.3

0.37

118

530

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

5.01

12.38

1.0

1.2

mmol/l

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

243

2.69

12.36

1.3

1.2

—

(4306422)

125

635

1.98

11.64

1.2

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

617

4611

1.36

11.51

1.8

1.7

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1939

22348

0.83

11.38

4.2

4.6

22.6

22.1

0.56

948

11694

(3002256) Pathology report gross observation

714

9198

0.76

11.25

1.3

—

(36304419) Bacteria [Presence] in Urine

2237

19534

1.19

11.16

3.9

3.2

—

(3000850) Epithelial cells [#/volume] in Urine

1833

15717

1.21

11.14

3.3

2.7

e6/l

5.3

5.0

0.38

1671

13707

(3052851) Hemolysis interference index of Serum or Plasma

324

2168

1.51

11.09

3.9

3.4

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

127

662

1.93

11.00

1.2

1.1

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1688

14386

1.21

10.90

2.2

1.7

mg/l

1.6

1.4

1.12

1375

11118

(4268621)

442

2.14

10.81

2.5

2.2

—

(3015736) pH of Urine

2903

25993

1.17

10.67

4.3

3.7

—

5.7

—

(3014271) Vancomycin [Susceptibility]

472

2.07

10.22

3.1

—

(3001019) Free T4 and TSH panel - Serum or Plasma

1913

0.51

10.21

1.7

—

(40761511) CBC panel - Blood by Automated count

6503

67771

0.85

10.21

21.4

15.4

—

(3028626) Oxygen [Partial pressure] in Capillary blood

272

1787

1.54

10.17

4.0

2.9

kpa

8.1

7.9

1.77

245

1656

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

7.79

10.13

1.1

1.0

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

360

2.20

9.86

2.4

2.3

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

147

2.93

9.72

1.0

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

142

2.97

9.68

1.0

1.1

—

(3030467) Casts [#/volume] in Urine by Automated count

2303

20377

1.18

9.59

3.9

3.2

e6/l

0.5

0.03

1883

15488

(3022145) Colonoscopy Study observation

574

7453

0.75

9.53

1.3

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

145

2.90

9.35

1.0

1.1

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

578

7478

0.76

9.34

1.3

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

3.74

9.30

1.0

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

135

2.97

9.27

1.0

1.1

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

771

9588

0.79

9.15

1.2

u/ml

20.1

13.4

0.45

284

3436

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

148

2.85

9.02

1.0

1.1

—

(3002582) Erythrocytes [#/volume] in Urine

2496

22321

1.16

8.97

4.1

3.3

e6/l

62.1

116.3

3.43

2047

17286

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2315

20616

1.17

8.74

3.8

3.2

u/l

36.3

35.4

0.21

2174

19334

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

525

6819

0.76

8.73

1.3

1.4

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

3985

36904

1.14

8.70

6.5

6.0

umol/l

11.6

12.2

2.24

3776

34851

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

4.11

8.69

1.0

1.1

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

700

8748

0.78

8.64

4.5

4.6

33.9

32.8

1.73

524

5521

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

122

686

1.79

8.44

1.7

—

(40768797) Stomach Pathology biopsy report

755

9323

0.79

8.41

1.3

1.2

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

124

703

1.77

8.35

2.9

3.0

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

398

2927

1.38

8.28

2.0

1.8

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

4.21

8.17

1.0

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

731

5865

1.27

8.16

1.8

1.7

1.5

6.38

620

5022

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

3.57

8.10

1.0

1.1

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

3.57

8.10

3.6

5.1

—

(3013512) EKG study

1945

21886

0.86

8.04

4.5

4.2

—

(3040151) Glucose [Moles/volume] in Capillary blood

152

926

1.65

7.91

10.3

5.8

mmol/l

7.4

7.3

0.11

125

749

(3028271) Lactate [Moles/volume] in Capillary blood

196

1270

1.55

7.90

2.1

1.9

mmol/l

1.9

1.7

2.35

170

1243

(3017143) Hepatitis C virus Ab [Presence] in Serum

682

5450

1.27

7.87

1.7

1.5

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

4634

49090

0.88

7.71

3.9

pmol/l

15.0

0.23

4172

43638

(3011985) Renin [Units/volume] in Plasma

138

828

1.68

7.63

1.3

1.4

mu/l

54.2

49.6

0.13

124

730

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1440

12462

1.19

7.62

3.1

2.9

e6/l

1.2

0.03

900

7234

(3021901) Oxygen saturation in Capillary blood

222

1492

1.50

7.57

3.5

2.8

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

422

3178

1.34

7.57

2.2

1.9

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

245

1684

1.47

7.48

1.4

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

245

1684

1.47

7.48

1.4

1.3

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

108

2.97

7.47

1.1

1.3

—

(3024928) Oxygen saturation in Venous blood

218

1467

1.50

7.40

3.8

2.9

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

2463

22269

1.15

7.32

2.9

2.5

u/l

59.3

59.5

0.05

2302

20436

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

130

778

1.68

7.28

1.4

1.3

pmol/l

253.9

301.6

0.51

601

(3045716) Anion gap in Serum or Plasma

325

2.07

7.25

2.0

2.1

mmol/l

9.4

9.1

0.20

251

(3039443) Prostate specific Ag panel - Serum or Plasma

1179

0.49

7.11

1.4

1.6

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

804

6627

1.23

7.08

2.3

2.1

g/l

0.2

0.16

746

6091

(3023103) Potassium [Moles/volume] in Serum or Plasma

6749

69653

0.87

7.05

27.7

19.0

mmol/l

4.0

11.49

6583

67555

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

3.85

6.96

1.0

1.1

—

(3042733) HLA Ab [Presence] in Serum

159

2.52

6.89

4.9

4.8

—

(3010421) pH of Blood

285

2051

1.40

6.81

4.7

4.3

7.4

1.00

225

1741

(3026250) Tacrolimus [Mass/volume] in Blood

209

2.30

6.80

38.8

32.3

ug/l

7.1

7.3

0.16

189

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

858

10204

0.82

6.65

1.2

1.3

iu/ml

49.4

37.6

0.82

244

3131

(3018095) Leukocytes [#/volume] in Urine

2770

25379

1.13

6.58

4.7

3.8

e6/l

96.9

122.9

1.30

2170

18476

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

530

1.78

6.55

1.1

—

(40768446) Kidney Pathology biopsy report

207

2.28

6.50

1.7

1.6

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

367

1.94

6.49

1.3

1.5

umol/l

13.3

14.1

0.38

344

(3019550) Sodium [Moles/volume] in Serum or Plasma

6744

69498

0.88

6.42

28.1

18.9

mmol/l

139.3

139.6

17.19

6595

67516

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

108

639

1.70

6.36

1.8

1.7

—

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

3.66

6.18

1.9

1.1

24.1

24.0

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

431

1.84

6.15

1.1

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

691

8317

0.82

6.04

3.2

4.0

ug/l

23.9

26.5

0.12

585

6846

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

910

7738

1.20

5.84

3.2

2.7

umol/l

9.3

9.5

0.09

786

6709

(3034426) Prothrombin time (PT)

154

2.41

5.84

1.3

1.2

—

(3023419) Bacteria identified in Sputum by Culture

146

952

1.54

5.84

1.9

2.4

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1322

11606

1.16

5.77

3.5

3.1

e6/l

2.4

0.04

787

6445

(40767503) Oxygen content in Capillary blood by calculation

237

1704

1.40

5.76

2.8

2.6

16.4

15.8

1.02

122

880

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

3.07

5.75

1.1

1.0

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

716

5969

1.22

5.67

1.7

1.5

—

(3028707) Methadone [Presence] in Urine by Screen method

408

1.82

5.61

2.7

2.4

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

3.10

5.60

2.0

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

3142

33658

0.90

5.56

2.6

2.5

—

(3024316) Viscosity of Plasma

4.49

5.50

1.9

1.7

mpas

1.6

1.7

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

241

3268

0.73

5.46

1.2

1.3

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

471

1.75

5.43

1.1

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

3.28

5.29

1.8

2.0

umol/l

18.2

18.1

0.01

(3000492) Spirometry study

442

5499

0.79

5.28

1.4

1.5

—

(3022313) Gas panel - Capillary blood

434

3455

1.27

5.26

4.7

3.7

—

(3035350) Ketones [Presence] in Urine by Test strip

3540

33209

1.11

5.24

4.6

3.9

estimate

0.0

0.50

621

6156

(4094501)

117

1796

0.65

5.24

1.1

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

504

6160

0.81

5.13

1.6

—

(3027315) Oxygen [Partial pressure] in Blood

243

1794

1.36

5.08

4.8

4.3

kpa

8.3

8.4

0.28

226

1747

(3013139) Helicobacter pylori Ag [Presence] in Stool

326

4189

0.77

5.08

1.2

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

253

1880

1.36

5.08

1.5

1.6

—

(3041096) Erythrocytes [Presence] in Urine by Automated

1584

17572

0.88

5.00

4.5

3.7

—

(40768793) Breast Pathology biopsy report

1334

0.60

4.95

1.3

—

(3012501) Base excess in Blood by calculation

241

1785

1.36

4.95

4.8

4.3

mmol/l

2.7

0.09

155

1226

(3013290) Carbon dioxide [Partial pressure] in Blood

241

1786

1.36

4.93

4.8

4.3

kpa

5.0

0.08

224

1740

(40768800) Prostate Pathology biopsy report

120

1805

0.66

4.90

1.3

1.2

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.12

4.90

1.0

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

106

2.55

4.86

1.1

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

110

1680

0.65

4.84

1.7

mg/l

5.0

3.7

0.31

1216

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

2763

25676

1.11

4.80

5.0

4.3

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

2.88

4.75

2.0

1.9

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

130

874

1.49

4.60

1.4

1.2

u/ml

268.8

282.8

0.25

535

(3044242) Glucose [Moles/volume] in Arterial blood

391

1.74

4.56

1.5

2.0

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

235

1760

1.34

4.53

2.4

2.2

g/l

130.3

126.4

1.23

168

1297

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

136

927

1.47

4.51

3.7

2.5

u/ml

1810.0

2010.8

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

400

4922

0.80

4.37

2.2

2.1

nmol/l

11.0

12.2

2.23

326

4267

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

226

1695

1.34

4.33

1.9

1.5

g/l

0.2

0.37

215

1598

(40757494) Bilirubin.total [Moles/volume] in Blood

413

1.70

4.30

2.1

2.3

umol/l

19.7

32.3

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

462

3797

1.23

4.28

1.6

g/l

1.5

1.6

0.34

390

3217

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

170

1221

1.40

4.27

6.8

5.2

iu/ml

1331.8

2577.5

0.35

179

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

126

2.30

4.25

1.0

1.1

—

(40768443) Skin Pathology biopsy report

248

3218

0.76

4.22

1.3

1.2

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

277

2154

1.29

4.12

1.9

1.6

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

155

2142

0.72

4.05

1.7

1.6

—

(3044889) 12 lead EKG panel

4616

48078

0.92

4.05

4.3

4.1

—

(3009261) Glucose [Presence] in Urine by Test strip

3558

33685

1.09

4.03

4.7

4.0

estimate

0.0

1.60

600

6064

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1386

0.65

4.03

1.4

1.3

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

132

917

1.45

4.01

1.5

1.4

u/ml

128.9

116.3

0.26

196

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1540

13983

1.12

4.00

2.9

3.1

mmol/l

2.5

0.01

1300

12097

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.72

3.91

1.1

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

336

4158

0.80

3.90

2.4

2.5

—

(3025315) Body weight

3.26

3.90

5.5

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

135

949

1.43

3.87

1.3

1.2

—

(3024932) HLA-DR beta [Type]

158

2.09

3.86

1.0

1.1

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

465

1.62

3.86

1.2

titre

112.3

135.2

0.30

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

465

1.62

3.86

1.2

titre

280.0

129.3

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

147

1050

1.41

3.85

1.6

1.4

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

191

1424

1.35

3.85

1.6

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

724

6265

1.17

3.83

2.7

2.4

u/l

40.7

45.0

0.18

618

5326

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

139

2.16

3.81

1.0

1.1

—

(44806118)

111

754

1.48

3.81

1.8

1.4

—

(44790049)

111

754

1.48

3.81

1.8

1.4

—

(44790048)

111

754

1.48

3.81

1.8

1.4

—

(44790047)

111

754

1.48

3.81

1.8

1.4

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

2.53

3.78

2.9

2.6

mg/l

68.4

83.1

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

2.53

3.78

11.5

13.2

mmol/l

5.3

5.4

0.01

(3052592) Norovirus Ag [Presence] in Stool

160

2.07

3.75

1.4

1.3

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

228

1754

1.31

3.72

1.9

1.5

g/l

1.2

0.89

217

1653

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

649

5586

1.17

3.68

3.2

2.7

ml/min/173m2

61.7

61.1

0.13

285

2339

(3019230) Fractional oxyhemoglobin in Venous blood

162

1189

1.37

3.63

4.1

2.4

62.2

63.1

0.19

162

1182

(1001926) Buprenorphine [Presence] in Urine by Screen method

104

706

1.48

3.60

2.6

1.9

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

247

1.83

3.59

2.6

2.7

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

208

1590

1.32

3.57

1.3

1.2

—

(1002224) Polysomnography panel

143

1955

0.73

3.55

1.1

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

811

7124

1.15

3.53

3.4

3.0

ng/l

270.6

241.8

0.99

724

6502

(3024471) HLA-A [Type]

164

2.02

3.53

1.0

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

224

2870

0.77

3.52

3.2

3.9

u/ml

186.4

79.1

0.37

215

2745

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

144

2.09

3.51

1.1

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

308

1.72

3.51

1.1

—

(3011288) Drugs identified in Urine by Screen method

581

1.52

3.49

4.1

2.8

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

264

3308

0.79

3.46

1.2

iu/ml

79.0

133.8

2.21

1189

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

440

1.59

3.45

1.9

1.7

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

244

1.81

3.42

1.0

1.1

u/l

1.2

1.1

0.22

128

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

362

2977

1.22

3.40

5.0

3.9

mmol/l

24.9

0.05

334

2693

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

121

856

1.42

3.40

1.4

1.3

nmol/l

0.1

0.3

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2564

27245

0.92

3.39

3.2

2.8

ug/l

167.5

153.3

1.29

2320

24657

(3051651) Icteric interference index of Serum or Plasma

380

1.64

3.39

3.1

3.3

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

238

1.81

3.37

1.0

1.1

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

231

1.82

3.36

1.1

ng/l

1480.5

394.8

0.40

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.83

3.35

1.3

1.2

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

2608

24516

1.09

3.33

3.2

3.3

mmol/l

2.3

2.4

2.74

2223

20857

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

881

7818

1.14

3.32

4.6

3.7

—

(1616796) Gas panel - Central venous blood

225

1760

1.29

3.28

4.5

3.7

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

204

1.87

3.28

1.3

1.5

pmol/l

16.3

0.02

163

(3021601) Nitrite [Presence] in Urine by Test strip

3495

33276

1.08

3.26

5.9

5.3

estimate

0.0

0.80

609

6200

(3016879) Cocaine [Presence] in Urine

119

847

1.41

3.25

2.6

1.9

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

2.78

3.24

1.6

1.3

mmol/l

26.6

22.4

—

(3017569) Oxygen content in Arterial blood

385

1.61

3.23

1.6

2.2

—

(4027681)

249

1.77

3.22

1.2

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.16

3.20

1.0

1.1

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

185

1415

1.31

3.20

1.5

1.3

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

111

783

1.42

3.19

1.4

1.3

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

185

1.89

3.17

1.1

miu/ml

1361.0

1613.6

0.72

185

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

458

1.55

3.16

1.2

—

(3017732) Neutrophils [#/volume] in Blood

382

4558

0.83

3.16

3.1

3.2

e9/l

3.9

4.2

1.25

275

3325

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

2056

19168

1.09

3.14

2.3

mg/l

3.3

3.1

2.39

1747

16180

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

453

1.55

3.09

1.0

ng/l

622.2

710.0

0.79

291

(3022806) Fractional oxyhemoglobin in Capillary blood

139

1027

1.36

3.06

1.9

88.7

89.1

0.27

125

1015

(3032352) Blasts [#/volume] in Cerebral spinal fluid

2.68

3.05

5.5

2.0

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

5.00

3.04

1.0

1.1

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

456

1.54

3.01

1.0

ng/l

42.4

45.5

0.21

293

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

263

1.71

2.97

1.1

ratio

1.1

0.45

(3027945) Reticulocytes/100 erythrocytes in Blood

1018

9183

1.12

2.96

2.5

2.3

1.9

1.8

2.30

895

7996

(3037121) Protein [Mass/volume] in Urine

305

2511

1.22

2.89

2.6

2.9

g/l

0.4

0.3

0.76

156

1013

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

163

1.90

2.88

1.1

1.0

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

124

1671

0.74

2.88

1.2

1.3

—

(3007566) Smooth muscle Ab [Titer] in Serum

202

1590

1.28

2.85

1.3

1.2

titre

67.5

119.6

1.84

129

(3019977) pH of Arterial blood

470

1.51

2.85

1.5

2.3

7.4

0.35

184

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

367

1.58

2.84

1.6

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

367

1.58

2.84

1.6

1.5

—

(3013707) Erythrocyte sedimentation rate by Westergren method

4798

49531

0.93

2.84

4.2

4.1

mm/h

15.3

14.0

6.43

4467

45029

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

455

1.52

2.83

1.0

ng/l

347.2

337.2

0.08

300

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

213

1690

1.27

2.82

1.8

1.6

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

448

1.52

2.80

1.3

1.2

—

(3021440) Promyelocytes/100 leukocytes in Blood

496

5722

0.86

2.78

4.3

4.0

0.1

0.02

157

1683

(40758292) HTLV I+II Ab panel - Serum

2.26

2.76

1.2

1.4

—

(3034770) Mitochondria Ab [Titer] in Serum

202

1598

1.27

2.75

1.2

titre

788.3

947.4

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

474

1.50

2.75

2.3

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

654

0.59

2.74

1.0

1.1

u/ml

2.4

3.3

—

237

(46235355) HIV 1 and 2 tests - Meaningful Use set

775

6917

1.13

2.71

1.8

1.6

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

6.00

2.69

2.8

2.1

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

6.00

2.69

2.8

2.6

—

(3008898) HLA-B27 [Presence]

106

1446

0.73

2.69

1.0

1.1

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

518

1.47

2.68

1.5

1.4

—

(1617658) Protocol used for examination of sentinel lymph nodes

458

0.52

2.67

1.0

1.1

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

105

761

1.38

2.65

1.4

1.3

nmol/l

—

(3000764) Benzodiazepines [Presence] in Urine

122

907

1.35

2.63

2.6

1.9

—

(3027008) Opiates [Presence] in Urine

123

916

1.35

2.62

2.6

1.9

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

218

1752

1.25

2.62

1.8

1.6

—

(3028300) Cannabinoids [Presence] in Urine

123

918

1.34

2.59

2.6

1.9

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

2.73

2.54

1.1

1.2

u/l

12.4

16.7

0.26

(3045424) Erythrocytes [Presence] in Urine

1149

0.71

2.48

1.6

1.5

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

410

3524

1.17

2.47

1.5

1.3

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

637

1.40

2.44

2.0

u/l

4182.5

2072.1

0.36

240

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

123

929

1.33

2.42

1.1

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

530

1.44

2.41

1.5

1.4

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

234

1.67

2.40

1.5

2.1

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

234

1.67

2.40

1.5

2.1

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

228

2771

0.82

2.36

3.1

3.3

u/ml

782.7

1853.5

0.94

195

2353

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

591

1.41

2.36

1.8

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

591

1.41

2.36

1.8

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

591

1.41

2.36

1.8

1.6

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

282

1.60

2.35

13.0

3.4

mg/l

77.2

64.5

0.31

186

(40758558) Short blood count panel - Blood

1808

16966

1.08

2.33

7.0

6.6

—

(3027944) Amphetamines [Presence] in Urine

118

893

1.33

2.31

2.6

1.8

—

(3025159) Blasts/100 leukocytes in Blood

468

5340

0.87

2.30

4.2

4.0

0.1

0.4

1.06

130

1398

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

2.18

2.30

6.2

5.1

ug/min

55.8

55.3

0.01

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

348

1.53

2.28

1.1

mg/l

56.1

45.3

0.65

287

(3027456) Digoxin [Moles/volume] in Serum or Plasma

234

1929

1.22

2.27

3.3

3.1

nmol/l

0.8

1.85

179

1469

(3005719) IgG [Mass/volume] in Serum or Plasma

529

4668

1.14

2.25

2.4

2.7

g/l

11.0

10.6

1.14

476

4238

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

333

1.53

2.25

1.1

mg/l

370.7

308.0

0.97

288

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

3.89

2.25

1.0

1.1

—

(3017181) Myelocytes/100 leukocytes in Blood

533

6016

0.88

2.24

4.3

3.9

1.2

0.9

1.28

169

1807

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

286

1.58

2.23

1.1

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

974

8913

1.10

2.22

4.5

4.0

u/l

259.6

248.9

0.78

908

8357

(3021589) Normoblasts [#/volume] in Blood

2798

29246

0.94

2.21

11.5

10.1

e9/l

0.0

0.09

2327

23800

(4146454)

832

0.68

2.21

2.0

2.7

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

264

2209

1.20

2.20

1.3

1.2

u/ml

1.6

1.0

0.33

212

(3002179) Metamyelocytes/100 leukocytes in Blood

478

5427

0.87

2.20

4.2

3.8

0.9

0.6

0.93

118

1289

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

640

5726

1.13

2.20

4.7

3.6

ng/l

109.1

93.6

2.98

541

4804

(40761536) Microorganisms panel - Urine sediment

524

5892

0.88

2.09

5.8

4.3

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1140

12298

0.92

2.08

1.2

u/ml

1.6

1.9

0.38

310

3082

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

284

1.55

2.07

4.5

5.1

u/ml

1528.0

669.3

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

272

2299

1.19

2.06

1.6

titre

107.3

258.0

2.00

109

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

293

1.54

2.04

1.4

—

(3000093) Morphology [Interpretation] in Blood Narrative

730

1.33

2.01

1.1

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

115

888

1.30

1.99

1.1

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

297

0.50

1.95

1.1

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

222

1853

1.20

1.94

1.2

—

(3051611) Lipemic interference index of Serum or Plasma

726

1.33

1.94

3.4

3.2

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

2.19

1.94

1.1

1.0

—

(3032057) Clostridioides difficile [Presence] in Stool

172

1.69

1.92

1.8

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

363

1.46

1.91

1.5

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

363

1.46

1.91

1.5

1.4

—

(3022948) Iron [Moles/volume] in Serum or Plasma

1282

11962

1.08

1.91

2.9

2.5

umol/l

11.9

12.3

1.24

1160

10914

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

227

2695

0.84

1.90

1.7

1.8

—

(3020630) Protein [Mass/volume] in Serum or Plasma

732

6661

1.11

1.89

2.4

2.5

g/l

65.3

66.1

1.67

640

5921

(3005322) IgE [Units/volume] in Serum or Plasma

288

3350

0.85

1.89

1.2

1.3

u/ml

299.2

243.6

0.20

266

3052

(3048689) Calprotectin [Mass/mass] in Stool

605

6699

0.90

1.89

2.0

2.1

ug/g

175.0

150.6

0.66

487

5195

(42529406) Shigella sp [Presence] in Stool by Culture

222

1860

1.20

1.88

1.2

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

2.15

1.87

1.1

1.0

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

203

2425

0.83

1.83

1.6

1.7

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

285

1.51

1.83

1.1

1.2

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2662

27729

0.94

1.83

2.3

2.2

nmol/l

76.3

79.2

5.79

2358

24236

(3023520) Reticulocytes [#/volume] in Blood

762

6966

1.10

1.81

2.6

2.5

e9/l

72.6

67.8

2.36

568

5327

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

485

1.38

1.81

1.1

—

(3020393) Adenovirus Ag [Presence] in Stool

2.06

1.80

1.7

1.1

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

3.04

1.79

1.9

5.9

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

463

0.62

1.78

1.3

1.4

nmol/l

0.3

0.2

0.38

338

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

1150

0.76

1.78

1.8

1.9

pmol/l

182.5

201.7

1.11

1069

(3045788) Cell count panel - Pleural fluid

110

860

1.28

1.77

1.6

1.5

—

(4035726)

569

6296

0.90

1.77

1.4

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

371

1.43

1.74

1.1

—

(3035637) Corticotropin [Mass/volume] in Plasma

766

1.30

1.73

1.5

1.6

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

218

1841

1.19

1.72

1.2

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

3.85

1.71

4.4

4.2

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

130

1610

0.80

1.71

2.9

3.2

u/ml

1671.4

716.7

0.40

120

1458

(44816559) Phosphatidylethanol [Mass/volume] in Blood

117

927

1.27

1.71

1.5

1.3

—

(3026493) Urate [Moles/volume] in Serum or Plasma

1779

18722

0.94

1.69

3.0

2.8

umol/l

4976.0

5989.5

0.42

1527

15868

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

2.00

1.69

1.1

1.2

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

419

0.62

1.68

1.7

1.4

pmol/l

96.8

132.5

—

131

(3028026) IgM [Mass/volume] in Serum or Plasma

416

3697

1.13

1.67

1.8

1.9

g/l

1.2

1.4

0.96

360

3310

(4010399)

433

4847

0.89

1.66

1.5

1.4

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

2.03

1.64

1.1

—

(4281824)

713

0.71

1.64

1.3

1.2

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

3.57

1.61

1.0

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

3.57

1.61

1.0

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

3.57

1.61

1.0

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

319

1.44

1.61

1.2

—

(3011648) Oxygen content in Venous blood

514

1.34

1.60

2.2

2.3

10.1

10.8

0.82

514

(3000330) Specific gravity of Urine by Test strip

357

4026

0.88

1.57

3.6

3.8

—

(40768795) Lymph node Pathology biopsy report

695

0.72

1.56

1.2

—

(3020650) Glucose [Presence] in Urine

156

0.45

1.54

1.3

1.5

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

192

1.56

1.53

1.2

1.6

g/l

13.1

13.7

0.11

151

(3007164) IgA [Mass/volume] in Serum or Plasma

1011

10809

0.93

1.52

1.5

g/l

2.9

2.6

2.63

610

6262

(3042517) Benzodiazepines panel - Urine

2.86

1.50

1.2

1.7

—

(40757373) Influenza virus identified in Isolate

146

1.64

1.50

1.2

1.6

—

(3037467) Urinalysis macro (dipstick) panel - Urine

4841

47328

1.05

1.49

5.3

4.6

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

129

1055

1.23

1.47

1.7

1.5

—

(3045414) Leukocytes [Presence] in Urine

266

3043

0.87

1.47

2.0

—

(3036525) Urea [Moles/time] in 24 hour Urine

2.22

1.46

2.9

3.3

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

2.37

1.45

2.3

2.4

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

1036

0.78

1.45

1.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

263

2292

1.15

1.45

1.5

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

867

0.76

1.45

1.2

1.3

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

136

1121

1.22

1.44

2.7

2.5

—

(3041354) Potassium [Moles/volume] in Venous blood

138

1140

1.21

1.43

2.6

2.4

mmol/l

4.0

4.1

1.37

138

1128

(3035285) Chloride [Moles/volume] in Venous blood

138

1140

1.21

1.43

2.6

2.4

mmol/l

105.3

105.5

0.22

138

1128

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

328

0.61

1.43

1.1

—

(3015183) Erythrocyte sedimentation rate

214

0.51

1.43

1.2

1.3

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

346

1.39

1.1

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

347

1.38

1.37

1.1

1.0

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

407

1.35

1.37

2.4

1.8

u/field

2.1

2.4

0.16

280

(3028308) Erythrocytes [#/volume] in Pleural fluid

124

1019

1.22

1.37

1.5

1.4

e6/l

59632.9

70941.4

0.20

591

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

2.20

1.36

1.0

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

2.61

1.36

2.3

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

124

0.40

1.35

1.2

1.7

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

151

1.59

1.34

1.2

1.1

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

334

2979

1.13

1.32

1.6

1.5

u/ml

11.3

19.9

1.20

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

683

0.74

1.31

1.2

mmol/l

7.7

0.02

482

(3023430) Cat dander IgE Ab [Units/volume] in Serum

416

0.67

1.31

1.1

u/ml

6.3

3.5

—

170

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

270

0.59

1.30

1.3

1.1

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

556

0.72

1.30

1.3

1.6

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

2.09

1.30

1.2

—

(3026470) Cobalt [Mass/volume] in Blood

509

0.71

1.29

1.9

ug/l

3.4

0.00

447

(3014133) Dog dander IgE Ab [Units/volume] in Serum

450

0.69

1.29

1.1

u/ml

4.6

2.4

0.30

179

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

2.78

1.28

1.0

1.1

mmol/l

—

(3025577) Chromium [Mass/volume] in Blood

496

0.70

1.28

1.9

2.0

ug/l

1.9

2.1

0.27

416

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

119

1434

0.83

1.27

1.0

1.1

u/ml

1.1

10.4

—

130

(3028679) Herpes simplex virus Ab [Presence] in Serum

218

1.47

1.27

1.1

—

(3023199) Leukocytes [#/volume] in Pleural fluid

135

1129

1.20

1.27

1.5

e6/l

4240.1

2156.9

0.46

805

(3001604) Monocytes [#/volume] in Blood

3387

32933

1.05

1.26

6.0

5.5

e9/l

0.6

4.00

2943

27927

(3048929) Epstein Barr virus Ab [Presence] in Serum

151

1277

1.19

1.25

1.3

1.2

—

(3028433) Virus identified in Specimen by Culture

227

1.45

1.25

1.1

1.2

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

660

1.26

1.25

2.0

—

2.8

—

(3021960) Folate [Moles/volume] in Serum or Plasma

1869

17922

1.05

1.24

1.6

nmol/l

18.6

20.2

4.41

1656

15118

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

153

1297

1.18

1.24

1.9

1.7

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

159

0.50

1.24

1.5

1.1

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

6545

66244

0.95

1.23

23.3

15.9

mg/l

26.4

26.9

0.54

5805

53698

(3006315) Basophils [#/volume] in Blood

3406

33142

1.04

1.22

6.0

5.6

e9/l

0.0

1.32

2966

28137

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

663

0.75

1.22

3.2

3.6

u/ml

74.8

40.1

0.43

649

(3002621) Streptococcal DNAse B [Units/volume] in Serum

1.96

1.21

1.0

1.1

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

707

0.76

1.20

1.1

u/ml

0.3

1.7

4.01

290

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

246

1.42

1.20

2.0

1.8

ug/l

68.5

53.5

0.33

236

(3003740) Influenza virus B Ag [Presence] in Specimen

624

0.75

1.16

1.2

1.1

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

133

1.58

1.16

1.2

umol/24h

0.9

0.7

—

(3025549) Creatine [Moles/time] in 24 hour Urine

2.00

1.16

1.5

1.4

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

102

1.67

1.15

1.4

1.3

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

2.05

1.15

1.0

—

(40765096) Chromosome analysis panel by Banding

210

0.57

1.14

1.1

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

361

1.33

1.12

1.3

1.1

u/l

50.4

26.0

0.65

280

(3004451) EKG impression Narrative

396

1.31

1.12

1.3

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

2.00

1.12

1.1

1.3

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

267

1.39

1.11

2.2

2.1

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

267

1.39

1.11

2.2

2.1

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

167

1.50

1.11

1.8

1.3

g/l

86.9

28.2

0.50

128

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

5276

53598

0.96

1.11

8.4

7.4

u/l

83.1

80.7

2.06

4951

50061

(3020682) Albumin/Creatinine [Ratio] in Urine

2248

23241

0.96

1.11

3.9

mg/mmol

16.5

9.0

5.28

1503

14609

(3004616) Nuclear Ab [Presence] in Serum

753

0.78

1.10

1.2

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

362

1.33

1.10

1.3

1.1

u/l

99.9

89.2

0.24

289

(36660697) Celiac disease serology panel - Serum

399

4359

0.91

1.06

1.2

—

(3002523) Influenza virus A Ag [Presence] in Specimen

625

0.77

1.06

1.2

1.1

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

161

1.49

1.06

1.2

1.1

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

236

2649

0.89

1.05

1.0

1.1

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1.96

1.03

1.0

1.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

240

0.62

1.03

1.0

1.2

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

199

2254

0.88

1.03

1.1

u/ml

1.1

1.6

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

150

0.53

1.02

1.1

1.9

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

2.06

1.02

1.3

1.2

—

(21494434) Karyotype in Bone marrow

643

1.23

1.02

1.3

1.2

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

146

1688

0.86

1.02

3.9

3.6

mg/l

31.2

29.5

0.19

102

1099

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

143

1655

0.86

1.01

1.6

1.7

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

264

1.36

1.01

2.1

2.0

e6/l

1469.5

5892.2

0.66

184

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

151

1306

1.16

1.01

1.5

1.4

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

1.88

1.00

1.0

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1098

10446

1.06

1.00

3.1

2.5

22.0

21.8

0.13

915

8726

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

2.00

1.00

4.6

3.2

—

(3019198) Lymphocytes [#/volume] in Blood

3462

33822

1.04

0.98

6.1

5.6

e9/l

1.8

1.9

4.51

3027

29261

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

2.17

0.98

3.6

1.8

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

706

0.79

0.98

1.3

1.2

—

(40760892) CBC W Ordered Manual Differential panel - Blood

1315

13727

0.95

0.98

4.8

4.5

—

(3042631) Mycobacterium sp identified in Specimen

1162

0.84

0.95

2.3

2.8

—

(3022689) Creatine [Moles/volume] in Urine

198

0.61

0.95

2.4

1.4

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

524

0.76

0.95

1.1

u/ml

1.6

2.3

—

131

(3021387) Prolactin [Units/volume] in Serum or Plasma

130

1119

1.16

0.94

1.9

1.7

mu/l

283.7

305.2

0.55

120

1033

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1163

11104

1.05

0.94

3.0

2.5

g/l

2.2

2.3

2.66

1055

10133

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

347

1.30

0.92

2.1

1.9

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

347

1.30

0.92

2.1

1.9

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

347

1.30

0.92

2.1

1.9

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

347

1.30

0.92

2.1

1.9

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

269

1.34

0.92

2.3

2.1

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

129

1113

1.16

0.91

1.4

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.67

0.91

1.5

1.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.67

0.91

1.5

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.67

0.91

1.5

1.2

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

699

1.20

0.90

2.3

2.2

u/field

3.5

1.7

1.11

255

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

118

1.53

0.90

5.6

7.6

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

102

1.57

0.90

2.3

1.7

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

103

0.48

0.89

1.0

1.1

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

198

1766

1.12

0.87

1.7

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

561

0.78

0.87

1.7

1.5

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

200

1786

1.12

0.87

5.3

2.9

mg/l

1.8

1.7

0.59

185

1590

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

879

0.83

0.86

1.1

iu/ml

28.2

1109.2

0.91

191

(3029396) Erythrocyte agglutination [Presence] in Blood

1.82

0.85

1.7

2.2

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

128

1.48

0.85

1.3

1.2

—

(1761482) Bacteria [#/volume] in Urine by Culture

207

2304

0.90

0.85

4.6

4.5

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

2481

24153

1.04

0.84

3.2

3.1

ng/l

1858.7

1789.8

0.29

2167

20845

(3043410) Blood group antigens tested for on Red Blood Cells

196

1.38

0.83

1.5

1.6

—

(3051101) Glucose [Moles/volume] in Cord blood

166

0.60

0.83

2.9

6.7

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

799

1.18

0.82

1.1

g/l

1.6

1.5

0.59

710

(3038071) Oxygen [Partial pressure] in Mixed venous blood

146

1.44

0.82

5.5

7.8

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

284

1.30

0.81

1.1

1.3

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

4040

39682

1.03

0.81

3.9

3.1

u/l

67.3

54.1

8.01

3768

35964

(3036312) Salmon IgE Ab [Units/volume] in Serum

0.00

0.79

0.0

1.1

—

0.4

—

(3023420) DNA double strand Ab [Units/volume] in Serum

564

1.21

0.78

2.3

1.3

iu/ml

49.1

20.1

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

150

1327

1.13

0.78

1.5

1.4

iu/l

32.2

33.4

0.14

116

1137

(3030905) Polymorphonuclear cells [#/volume] in Blood

115

1319

0.87

0.78

4.3

3.2

e9/l

4.4

4.3

0.08

115

1314

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

361

0.75

0.77

1.1

1.0

u/ml

0.1

0.4

—

102

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

167

1.38

0.73

1.5

1.2

g/l

0.3

0.32

128

(3013115) Eosinophils [#/volume] in Blood

3490

34250

1.03

0.72

6.3

5.7

e9/l

0.2

0.40

3070

29473

(40759836) Histone Ab [Presence] in Serum by Immunoblot

370

1.24

0.72

1.2

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

370

1.24

0.72

1.2

1.1

—

(40768806) Pleura Pathology biopsy report

110

960

1.15

0.72

1.4

1.6

—

(3003327) Ova and parasites identified in Stool by Light microscopy

156

1742

0.89

0.71

1.6

1.7

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

443

1.22

0.71

1.6

1.5

u/l

6.8

6.4

0.06

209

(3012516) Albumin [Mass/volume] in Urine

2138

21929

0.97

0.71

3.3

3.2

mg/l

404.2

361.7

0.18

1455

13847

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

371

1.24

0.71

1.2

1.1

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

1.92

0.70

3.4

1.2

—

(3044009) aPTT.lupus sensitive (LA screen)

1.71

0.69

1.1

1.2

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

320

0.75

0.69

1.7

1.6

umol/l

8.9

9.7

0.12

217

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

132

1170

1.13

0.69

1.5

1.4

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.64

0.68

1.2

umol/24h

2.6

1.6

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

1.59

0.68

1.8

2.4

mmol/l

1.9

1.4

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

374

1.23

0.67

1.2

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

374

1.23

0.67

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

374

1.23

0.67

1.2

1.1

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

484

1.20

0.66

1.2

1.1

—

(4211845)

384

1.22

0.66

3.3

3.7

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

734

1.16

0.65

1.3

1.2

u/l

57.3

65.7

0.62

488

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

723

0.84

0.65

1.1

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

665

6331

1.05

0.65

4.7

3.9

mmol/l

1.2

2.69

581

5411

(3045683) HLA typing for celiac disease panel - Blood or Tissue

259

0.73

0.64

1.0

—

(3019225) pH of Specimen

728

7614

0.95

0.64

5.4

4.3

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

1.72

0.64

5.0

7.8

—

(40768441) Liver Pathology biopsy report

460

1.20

0.62

1.6

1.3

—

(3037556) Urate [Mass/volume] in Serum or Plasma

234

0.73

0.62

1.1

1.4

—

(3002030) Lymphocytes/100 leukocytes in Blood

3140

31948

0.97

0.62

6.6

6.0

24.5

26.5

20.64

2922

29262

(3008757) Leukocyte morphology finding [Identifier] in Blood

804

1.15

0.62

4.3

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

501

0.82

0.61

4.4

5.1

u/ml

31.2

67.6

1.35

142

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

501

0.82

0.61

1.2

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

588

0.83

0.61

1.1

u/ml

0.4

1.3

1.98

250

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

379

1.21

0.61

1.7

1.6

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

609

0.84

0.61

1.1

u/ml

4.8

4.0

0.12

287

(3041672) Baker's yeast Ab [Presence] in Serum

0.00

0.60

0.0

1.1

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

0.00

0.59

0.0

1.1

—

23.0

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

0.00

0.59

0.0

1.1

—

33.6

—

(3007542) Rye IgE Ab [Units/volume] in Serum

0.00

0.59

0.0

1.0

—

0.1

—

(44806071)

1.51

0.58

1.0

1.1

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

485

0.82

0.57

1.7

1.5

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

297

0.77

0.56

1.3

1.5

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

484

0.83

0.56

1.7

1.5

—

(3000012) Reticulocyte production index

484

0.83

0.56

1.2

1.5

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

263

0.76

0.56

1.4

1.2

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

263

0.76

0.56

1.6

ug/l

24.8

8.6

0.44

231

(3012441) Differential panel - Pleural fluid

109

972

1.12

0.56

1.5

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

272

2536

1.07

0.55

1.3

—

(3000494) Fungus identified in Specimen by Culture

737

7670

0.96

0.55

1.6

1.4

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

148

0.68

0.55

1.3

1.1

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

184

2000

0.92

0.54

1.4

1.3

—

(3003434) Protein [Mass/volume] in Pleural fluid

142

1288

1.10

0.54

1.6

1.5

g/l

32.8

31.6

0.55

125

1148

(3035933) Granulocytes/100 leukocytes in Blood

126

0.63

0.54

1.4

1.5

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

1.41

0.54

1.1

u/l

17.0

18.8

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

899

0.88

0.54

1.6

1.4

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

153

1394

1.10

0.53

1.3

1.2

titre

80.0

181.2

—

(3006462) Nitrate [Presence] in Urine

349

1.20

0.53

3.3

3.8

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

1.49

0.53

1.7

1.9

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.54

0.53

1.0

1.1

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

169

1.30

0.53

5.3

7.8

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

371

0.81

0.52

1.5

g/l

1.0

0.09

371

(3005988) Vibrio sp identified in Specimen by Organism specific culture

897

0.88

0.52

1.6

1.4

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

0.61

0.52

1.2

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

894

0.88

0.50

1.6

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

894

0.88

0.50

1.6

1.4

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

1.47

0.50

1.5

—

(3004809) Band form neutrophils/100 leukocytes in Blood

119

1314

0.90

0.50

3.8

3.6

2.0

1.5

0.67

990

(3032868) Hemoglobin electrophoresis panel in Blood

1.46

0.50

1.5

1.4

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.40

0.48

4.6

2.5

u/field

0.5

0.4

0.31

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

121

1098

1.10

0.48

1.5

—

(3044007) Cell count panel - Peritoneal fluid

217

1.24

0.47

2.2

1.9

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.49

0.47

1.3

1.1

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

200

1.25

0.46

1.0

1.3

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

364

0.82

0.46

5.8

6.3

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

232

0.78

0.45

1.3

1.5

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.61

0.45

2.0

1.5

—

(3000285) Sodium [Moles/volume] in Blood

120

0.67

0.45

1.0

1.1

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

209

0.76

0.45

1.1

1.2

—

(4015189)

209

0.76

0.45

2.3

2.5

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

144

1563

0.92

0.44

1.4

1.3

—

(3025130) Human papilloma virus identified in Specimen

480

0.85

0.43

1.7

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

191

2047

0.93

0.43

1.4

ug/g

263.2

266.1

0.07

110

1229

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

1.41

0.43

1.0

1.2

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

1039

0.90

0.43

1.1

1.2

—

(3036603) Volume of Urine

436

0.85

0.42

1.5

1.6

1834.9

1814.3

0.03

117

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

382

0.84

0.42

1.3

1.4

u/ml

1.9

1.5

0.09

194

(3033799) Differential panel - Peritoneal fluid

239

1.21

0.42

1.9

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

229

0.79

0.42

1.3

1.4

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

240

0.79

0.42

1.4

1.5

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.40

0.42

4.6

5.1

—

(3033942) Copper [Moles/time] in 24 hour Urine

0.00

0.41

0.0

1.1

—

0.2

—

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

0.6

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

0.40

0.0

1.0

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

114

1.32

0.40

1.5

1.2

—

(3044941) Cell count panel - Synovial fluid

120

1101

1.09

0.40

1.4

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

205

0.78

0.40

1.3

1.4

—

(3005033) Fetal Nuchal fold Thickness US

227

0.79

0.40

1.3

1.4

—

(42868555) Amyloid beta 40 peptide [Mass/volume] in Cerebral spinal fluid

0.00

0.40

0.0

1.0

—

11767.3

—

(3042301) Urate [Moles/volume] in Synovial fluid

0.00

0.40

0.0

1.1

—

351.9

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

408

1.15

0.40

1.1

1.2

mmol/l

9.6

11.8

0.94

135

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

102

0.69

0.39

1.0

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

1.43

0.39

1.8

1.3

—

(3045142) Bone marrow Pathology biopsy report

823

0.90

0.39

1.4

1.3

—

(3007700) Barley IgE Ab [Units/volume] in Serum

0.00

0.39

0.0

1.0

—

0.1

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

0.00

0.39

0.0

1.4

—

12.2

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

106

0.66

0.39

1.0

1.2

—

(3036071) Salmonella sp Ab [Titer] in Serum

159

0.75

0.38

1.2

1.1

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

102

932

1.10

0.38

1.7

1.6

g/l

0.7

0.8

0.29

692

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

122

1124

1.09

0.38

1.5

1.4

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

233

1.20

0.38

1.8

e6/l

1387.2

18151.6

1.39

132

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

335

1.16

0.38

1.5

u/l

11.9

6.8

0.42

281

(3018010) Neutrophils/100 leukocytes in Blood

3105

31423

0.98

0.38

6.3

5.7

60.0

58.3

11.44

2906

28919

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

1.33

0.37

1.1

1.2

—

11.5

—

(44806420)

268

0.82

0.37

2.4

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

180

0.78

0.36

1.8

2.3

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

197

1853

1.06

0.36

2.4

2.3

ug/min

149.0

109.7

0.41

111

1052

(3009508) Creatinine [Moles/volume] in Urine

2215

22482

0.98

0.36

3.2

3.1

mmol/l

7.0

7.3

2.71

1867

18438

(3013727) Leukocytes other/100 leukocytes in Blood

267

0.82

0.36

3.4

3.8

49.0

54.7

0.53

256

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

113

1042

1.09

0.35

1.5

1.4

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

168

0.77

0.35

1.3

1.6

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.43

0.35

1.0

1.9

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

0.63

0.35

5.6

5.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

122

0.74

0.35

1.0

1.2

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

123

0.73

0.35

1.1

1.2

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

126

1356

0.93

0.35

1.7

iu/l

3.4

4.6

0.97

438

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

1.33

0.33

1.3

1.2

—

(3004588) Protein electrophoresis panel - Serum or Plasma

572

5537

1.03

0.33

2.3

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

124

1332

0.93

0.33

1.1

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.30

0.33

1.0

1.1

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

596

1.11

0.33

1.3

1.4

g/l

3.0

2.9

0.23

418

(3013650) Neutrophils [#/volume] in Blood by Automated count

3897

38598

1.02

0.32

8.9

8.7

e9/l

4.6

4.3

9.14

3441

33315

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

113

1217

0.93

0.32

1.3

1.2

u/ml

1.6

5.1

1.19

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

129

1382

0.93

0.32

1.3

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

220

1.18

0.31

1.0

1.1

—

(3035320) C reactive protein [Mass/volume] in Body fluid

496

0.89

0.31

2.1

2.5

—

(3004775) Volume in Urine collected for unspecified duration

622

0.90

0.31

2.5

2.2

759.2

643.4

0.96

382

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

913

0.92

0.31

1.6

1.4

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

389

0.87

0.30

2.1

ug/min

168.7

110.9

—

(4062490)

600

1.10

0.30

1.3

1.4

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

419

1.12

0.30

1.0

1.1

mg/l

300.3

286.7

0.67

377

(3014051) Protein [Presence] in Urine by Test strip

149

1581

0.94

0.29

2.2

2.3

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

483

0.89

0.29

1.3

1.2

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

687

1.09

0.29

1.4

1.2

u/ml

45.8

48.5

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

130

0.77

0.29

4.5

3.1

u/l

2787.5

2696.3

—

123

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

185

1.19

0.29

1.2

1.3

25.6

32.2

0.39

124

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

482

0.89

0.29

1.1

1.4

u/l

42.0

32.0

1.04

389

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

888

0.92

0.28

1.6

1.4

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

112

1.25

0.28

1.6

1.1

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

1.32

0.28

1.3

1.6

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

374

1.12

0.28

1.7

2.1

nmol/l

14.0

16.8

1.88

346

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

148

1566

0.94

0.27

1.3

1.2

u/ml

44.9

47.7

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

185

1758

1.05

0.27

1.5

1.6

iu/ml

0.1

8.8

1.25

415

(3003694) ABO and Rh group [Type] in Blood

1675

16500

1.02

0.27

1.3

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

370

3826

0.97

0.27

2.2

2.4

au/ml

35.4

23.9

0.49

155

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

102

952

1.07

0.27

1.5

1.2

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

334

3460

0.96

0.26

1.2

1.3

au/ml

61.6

50.7

0.39

154

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

1.21

0.26

1.1

1.0

—

(3023511) Choriogonadotropin [Units/volume] in Urine

262

1.15

0.26

1.3

—

(40765089) Chromosome analysis panel - Blood by G-banded

1.19

0.26

1.0

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

596

1.09

0.26

1.3

1.4

g/l

7.3

6.8

0.54

413

(3024139) IgG subclass 3 [Mass/volume] in Serum

596

1.09

0.26

1.3

1.4

g/l

0.5

0.4

0.30

414

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

178

1.18

0.26

1.2

1.3

nmol/l

115.2

137.9

0.18

130

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

877

1.07

0.25

1.8

1.6

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.23

0.25

1.9

1.4

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

415

1.11

0.25

1.3

1.2

u/l

130.6

85.5

0.66

358

(3049717) Cytology report of Urine Cyto stain

346

3344

1.04

0.25

2.8

—

(4133840)

151

1.19

0.25

1.2

—

(44813793)

340

0.88

0.25

1.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

378

1.11

0.24

2.8

3.3

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

850

1.07

0.24

1.3

u/l

404.4

402.6

0.01

804

(3001964) Herpes simplex virus Ag [Presence] in Specimen

180

0.83

0.24

1.8

1.5

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

0.74

0.24

9.2

13.1

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

133

1259

1.06

0.24

2.0

1.6

nmol/l

0.8

0.14

111

1045

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

0.72

0.24

1.0

1.1

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

130

1230

1.06

0.24

1.3

1.2

u/l

29.9

40.9

0.73

118

1055

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

1.32

0.23

9.6

1.1

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

332

1.11

0.23

1.3

nmol/l

1.0

1.2

0.64

257

(3020717) Zinc [Moles/volume] in Serum or Plasma

275

1.13

0.23

1.3

1.4

umol/l

19.7

23.7

0.38

262

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

228

1.14

0.22

1.8

u/ml

390.0

68832.7

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

284

0.88

0.22

1.2

1.4

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

284

0.88

0.22

1.4

33.9

17.8

1.76

249

(3016750) Collection duration of Urine

429

1.10

0.22

2.4

2.1

min

495.8

493.7

0.05

299

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

461

0.91

0.21

2.4

2.0

9.8

14.5

1.23

180

(3006567) Chloride [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.1

—

(3007919) Fasciola sp Ab [Titer] in Serum

0.00

0.21

0.0

1.0

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

0.00

0.21

0.0

1.1

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

0.21

0.0

1.2

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

220

0.86

0.21

1.1

1.2

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.21

0.0

1.8

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

283

0.88

0.21

1.2

1.4

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

138

1447

0.95

0.21

1.3

1.2

u/ml

2.8

6.9

0.74

144

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.9

—

2.4

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

925

1.06

0.20

1.6

1.8

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

282

0.89

0.20

1.2

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

282

0.89

0.20

1.2

1.4

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

0.20

0.0

1.4

—

2.5

—

(3019174) dRVVT (LA screen)

1.25

0.20

1.2

—

(3050129) First trimester maternal screen panel - Serum or Plasma

334

0.90

0.20

1.5

—

(3002619) Bacteria identified in Specimen by Culture

136

1.18

0.20

1.1

1.2

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

281

2723

1.03

0.20

2.9

3.1

mg/l

37.7

54.5

1.77

235

2184

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

674

1.07

0.19

1.3

u/l

10.8

14.3

1.57

620

(3000060) B lymphocytes [#/volume] in Blood

133

0.83

0.19

3.3

2.1

e6/l

110.0

1422.0

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

133

0.83

0.19

2.1

2.6

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.22

0.19

1.3

1.1

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

287

2785

1.03

0.19

2.5

2.7

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

404

1.09

0.19

1.7

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

281

2726

1.03

0.19

2.9

3.1

mg/l

51.9

81.9

0.78

235

2187

(4024509)

715

0.94

0.19

1.7

1.6

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

797

0.94

0.19

3.8

3.6

64.5

58.7

1.45

494

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

663

0.93

0.18

1.0

1.1

—

(3019069) Monocytes/100 leukocytes in Blood

3108

31282

0.99

0.18

6.8

6.1

9.0

8.8

2.22

2912

28839

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

153

0.85

0.18

1.8

1.4

6.0

8.4

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

166

1.14

0.18

1.1

1.2

—

(3024263) Appearance of Synovial fluid

383

0.91

0.18

1.3

1.6

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.17

0.17

1.4

1.0

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

590

1.07

0.17

1.4

1.3

nmol/l

1.3

1.4

0.40

527

(3014891) Appearance of Pleural fluid

138

1.16

0.17

2.0

1.6

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

299

0.90

0.17

1.0

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

141

1467

0.96

0.17

1.3

1.2

u/ml

4.1

7.7

1.45

227

(3024869) Neuronal Ab [Presence] in Serum

131

0.84

0.17

1.0

1.1

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

236

0.89

0.16

1.5

2.1

ug/l

28.8

183.3

0.70

217

(21494814) CD8 cells/100 lymphocytes in Specimen

267

0.90

0.16

2.3

1.9

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.16

0.16

1.8

umol/l

59.4

46.5

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

311

1.09

0.16

1.4

—

(3044927) Protein electrophoresis panel - Urine

833

0.95

0.16

1.3

1.2

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

272

2647

1.03

0.16

2.9

3.1

ratio

4.3

2.7

0.34

203

(3005011) Chlamydia sp Ab [Titer] in Serum

1.13

0.16

1.8

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

1.20

0.16

1.5

1.3

ug/l

64.5

111.4

1.33

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

214

0.89

0.15

1.4

1.7

—

(3017704) Immunofixation for Urine

457

1.07

0.15

1.5

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1663

16471

1.01

0.15

1.7

pmol/l

34975095.5

28649490.8

0.15

1381

13250

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

730

1.05

0.15

1.0

1.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

168

1.13

0.15

1.9

1.5

ug/l

13.0

9.3

1.40

168

(3011544) Albumin [Mass/volume] in Pleural fluid

1.11

0.15

1.1

g/l

15.3

17.7

—

(3025941) Bacteria identified in Stool by Culture

360

3524

1.02

0.14

1.3

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

1.18

0.14

1.4

1.6

—

61.2

—

(3006504) Eosinophils/100 leukocytes in Blood

3095

31106

0.99

0.14

6.5

5.8

2.8

2.9

1.16

2888

28568

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

160

1.12

0.14

3.7

2.6

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

3111

30936

1.01

0.13

2.1

pmol/l

89.8

93.6

4.64

1668

15979

(3022096) Basophils/100 leukocytes in Blood

3009

30238

0.99

0.13

6.5

5.8

0.6

0.7

3.05

2814

27795

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

132

1.14

0.13

4.7

4.6

u/l

42.8

39.9

—

(3047189) Immunofixation for 24 hour Urine

386

0.93

0.12

2.0

1.5

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

161

1.12

0.12

1.9

2.3

ug/l

2.0

1.1

0.56

153

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

212

2068

1.03

0.12

2.4

2.2

g/l

0.0

0.00

191

1883

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

244

2385

1.02

0.12

2.5

2.1

g/l

36.1

37.3

2.27

207

1992

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

354

0.93

0.12

1.1

1.3

—

(40760888) Immunoglobulin light chains.free panel - Serum

212

2069

1.02

0.12

2.9

3.3

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

364

0.93

0.12

2.9

2.4

e9/l

0.1

0.2

1.85

317

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

102

984

1.04

0.11

1.3

1.2

miu/ml

220.2

199.5

0.20

381

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

215

2100

1.02

0.11

2.4

2.2

g/l

0.0

0.06

191

1889

(3008116) Ketones [Moles/volume] in Urine by Test strip

143

1.12

0.11

1.1

1.3

—

(3005570) Glucose [Moles/volume] in Urine

759

1.04

0.11

1.9

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

121

1173

1.03

0.11

1.7

1.8

—

(3022621) pH of Urine by Test strip

484

4772

1.01

0.10

3.5

3.3

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

351

0.94

0.10

1.1

1.3

—

(3000034) Microalbumin [Mass/volume] in Urine

712

1.04

0.10

3.2

3.0

mg/l

16.4

40.1

1.76

519

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

1.11

0.09

1.0

1.8

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

422

0.95

0.09

3.0

4.0

—

(3008536) Aspergillus sp Ab [Presence] in Serum

135

1.11

0.09

2.6

1.8

—

(3036670) Protein [Mass/volume] in Synovial fluid

248

0.93

0.09

1.2

g/l

42.3

39.5

0.39

127

(3050794) Legionella sp Ab [Presence] in Serum

1.04

0.09

1.0

1.1

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

268

0.93

0.09

2.8

2.5

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

380

0.95

0.09

2.7

2.3

e6/l

344.3

507.6

2.07

319

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

233

1.07

0.09

2.2

1.8

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

892

1.03

0.08

1.6

1.5

57.0

62.2

0.73

560

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

165

1.09

0.08

1.6

1.3

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

674

0.96

0.08

1.6

1.5

25.8

28.0

0.23

420

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

0.82

0.08

2.4

6.2

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.82

0.08

1.2

3.1

—

(42870588) Differential panel, method unspecified - Blood

2322

23114

1.01

0.08

6.3

5.7

—

(3029075) Extractable nuclear Ab panel - Serum

146

1.10

0.08

1.0

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

943

1.03

0.08

2.0

1.6

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

136

1329

1.02

0.08

1.9

1.5

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

308

3121

0.99

0.08

2.4

2.2

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

258

2618

0.98

0.08

2.8

2.3

g/l

0.8

1.1

0.65

217

2181

(3001186) Copper [Moles/volume] in Serum or Plasma

127

1.10

0.07

1.1

umol/l

19.3

16.4

0.86

115

(3001729) Color of Synovial fluid

0.86

0.07

1.5

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

0.82

0.07

3.8

1.9

—

(3013293) Extractable nuclear Ab [Presence] in Serum

1.06

0.07

1.9

1.6

—

(3035880) pH of Pleural fluid

511

1.04

0.07

1.5

1.3

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

983

0.98

0.06

2.2

mg/l

29.1

26.8

0.10

256

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

259

2623

0.99

0.06

1.7

1.8

u/l

38.2

39.0

0.23

218

2259

(3003338) MCHC [Mass/volume]

5327

53337

1.00

0.06

29.2

20.9

g/l

331.5

331.6

0.38

5240

52762

(3006270) Folate [Moles/volume] in Blood

700

0.97

0.06

1.2

nmol/l

332.3

338.4

0.09

542

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

110

1076

1.02

0.06

1.5

1.4

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

581

1.03

0.06

1.3

1.2

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.11

0.06

1.3

1.1

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

105

0.86

0.06

1.1

1.0

—

(3048879) Bone marrow aspiration report

254

0.94

0.06

1.8

1.6

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

335

0.95

0.06

1.7

1.4

2.9

3.4

0.09

(3011412) CD3 cells [#/volume] in Blood

588

0.97

0.06

2.6

2.2

e9/l

0.9

1.1

1.13

376

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

414

1.04

0.06

2.4

e6/l

422.4

582.1

1.55

160

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

446

0.96

0.06

2.6

2.0

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

419

4151

1.01

0.06

3.4

2.8

e6/l

0.4

0.3

0.14

413

4069

(3000475) Leukocytes [#/volume] in Synovial fluid

179

1763

1.02

0.06

1.6

1.5

e6/l

18824.0

14687.7

0.57

131

1261

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

577

0.97

0.05

1.6

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

229

2262

1.01

0.05

2.4

2.2

g/l

0.0

2.41

205

2040

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

291

2880

1.01

0.05

2.5

2.2

g/l

3.2

3.1

0.61

222

2198

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

309

3118

0.99

0.05

2.4

2.2

g/l

3.9

3.8

0.62

220

2155

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

171

0.94

0.05

3.1

2.7

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

199

1.05

0.04

1.1

—

(3037522) Nuclear Ab [Titer] in Serum

782

7854

0.99

0.04

1.4

1.3

titre

575.7

502.4

0.49

181

1660

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

332

0.96

0.04

1.3

1.1

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

175

1770

0.99

0.04

1.5

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

160

0.94

0.04

1.6

1.2

mmol/l

1.4

1.6

—

101

(3037756) Immunofixation for Serum or Plasma

179

1810

0.99

0.04

1.5

1.6

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

664

0.98

0.04

1.6

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

163

1648

0.99

0.04

1.7

1.9

mg/l

12.2

11.9

0.11

146

1513

(3021788) Differential panel - Synovial fluid

127

1285

0.99

0.03

1.6

1.5

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

151

1.06

0.03

1.1

1.3

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

169

0.95

0.03

2.9

2.2

mmol/l

6.1

7.6

2.25

105

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

642

0.98

0.03

1.3

1.6

u/ml

36.5

24.8

0.71

141

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

261

1.03

0.02

1.3

ug/l

323.2

409.8

0.10

145

(3009214) Lutropin [Units/volume] in Serum or Plasma

114

1152

0.99

0.02

1.4

u/l

10.7

10.3

0.10

928

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

311

3125

0.99

0.02

2.4

2.2

g/l

7.5

7.4

0.17

224

2247

(3026389) Candida sp identified in Specimen by Organism specific culture

880

0.99

0.02

1.4

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

232

1.03

0.02

1.3

1.5

umol/l

27.0

30.6

1.34

225

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

123

1.06

0.01

1.5

1.6

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

143

1.05

0.01

1.3

1.1

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

207

0.97

0.01

1.3

1.6

umol/l

2.1

0.20

192

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

363

1.02

0.01

1.6

2.8

34.9

38.1

0.41

125

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

126

0.95

0.01

3.6

2.0

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

114

1.05

0.00

1.1

u/ml

0.3

1.7

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

154

1.04

0.00

1.6

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

154

1.04

0.00

1.6

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

154

1.04

0.00

1.6

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

154

1.04

0.00

1.6

1.1

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

126

1266

0.99

0.00

5.4

3.1

—

(3009871) Measles virus Ab [Titer] in Serum

142

0.99

0.00

1.8

1.7

—

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

464

0.99

0.00

2.9

3.6

nmol/l

255.6

175.2

0.27

458

(3037692) Legionella sp identified in Specimen by Organism specific culture

251

1.00

0.00

1.3

1.4

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

291

2913

1.00

0.00

2.5

2.2

g/l

10.1

10.3

0.27

235

2404

(3020491) Glucose [Moles/volume] in Blood

488

1.00

0.00

1.7

2.1

mmol/l

7.0

7.2

0.14

337

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

114

0.96

0.00

1.3

1.1

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

109

1090

1.00

0.00

1.4

1.2

u/ml

71.4

49.2

0.45

113

(3010144) Erythrocytes [#/volume] in Synovial fluid

705

1.01

0.00

1.4

1.3

e6/l

66840.9

145890.2

1.26

475

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

782

1.00

0.00

3.2

3.5

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

351

3505

1.00

0.00

3.0

3.2

pmol/l

4.3

4.4

1.16

306

3035

(21494890) Protein electrophoresis panel - 24 hour Urine

838

1.00

0.00

2.0

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

681

1.00

0.00

1.2

1.3

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.0

1.0

—

(3009992) Blasts/100 cells in Bone marrow

0.00

0.0

1.4

—

6.4

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

0.00

0.0

1.1

—

1.2

—

(3034614) HLA Ag [Interpretation]

0.00

0.0

1.4

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.0

—

(3007147) Virus identified in Stool by Electron microscopy

0.00

0.0

1.0

—

(3008860) Bordetella pertussis IgM Ab [Presence] in Serum

0.00

0.0

1.4

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

25.8

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

0.0

6.6

—

0.2

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

0.00

0.0

1.0

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

0.00

0.0

1.0

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

0.0

1.1

—

(3026726) Creatinine [Moles/volume] in Specimen

0.97

0.00

4.0

2.4

umol/l

244.3

552.0

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

0.00

0.0

1.0

—

(3002079) Sodium [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

138.7

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.00

0.0

1.0

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

0.00

0.0

1.0

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

0.00

0.0

2.4

—

(3028717) Thiamine [Mass/volume] in Blood

1.02

0.00

1.2

—

(3046594) Interleukin 8 [Mass/volume] in Serum or Plasma

0.00

0.0

1.1

—

38.7

—

(4212803)

0.94

0.00

1.0

—

(3027035) Albumin [Mass/time] in 24 hour Urine

0.87

0.00

1.8

1.3

—

539.1

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3015350) Toxocara sp Ab [Presence] in Serum

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint I9_INTRACRA and mortality.

Females

Parameter	HR [95% CI]	p-value
I9_INTRACRA	2.591 [2.34, 2.87]	< 0.001
Birth year	0.992 [0.98, 1.0]	0.052

During the follow-up period (1.1.1998 — 31.12.2019), 10433 out of 23218 females with I9_INTRACRA died.

Males

Parameter	HR [95% CI]	p-value
I9_INTRACRA	2.552 [2.3, 2.83]	< 0.001
Birth year	0.986 [0.98, 0.99]	0.002

During the follow-up period (1.1.1998 — 31.12.2019), 11486 out of 25311 males with I9_INTRACRA died.

Mortality risk

Mortality risk for people of age

years, who have I9_INTRACRA.

N-year risk	Females	Males
1	0.217%	0.367%
5	1.26%	2.51%
10	3.11%	7.178%
15	6.083%	12.82%
20	10.536%	20.875%

Relationships between endpoints

↥

Index endpoint: I9_INTRACRA – Nontraumatic intracranial haemmorrhage

GWS hits: 6

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Nontraumatic intracranial haemmorrhage

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints